Professor John GF Cleland

All Stories

Withholding beta-blockers after myocardial infarction: reasons to be cautious

Article • Cardiovascular Research, April 2026, Oxford University Press (OUP)

Professor John GF Cleland
Expert Perspectives on Managing Iron Deficiency in People with CKD and/or HF

Article • Journal of Clinical Medicine, February 2026, MDPI AG

Professor John GF Cleland, Dr Matthew Hall
Do we need exercise echocardiography to diagnose HFpEF? Not at all

Article • European Journal of Heart Failure, February 2026, Oxford University Press (OUP)

Dr Matthew M Y Lee, Dr Pierpaolo Pellicori, Professor John GF Cleland
Association between body mass index, plasma N-terminal pro-B-type natriuretic peptide, symptoms and outcome in patients referred for investigation of suspected heart failure

Article • Heart, February 2026, BMJ

Professor John GF Cleland, Dr Pierpaolo Pellicori
Impact of Loop Diuretics on Long-Term Kidney Outcome

Article • Kidney360, January 2026, Wolters Kluwer Health

Professor John GF Cleland
Reply to: ‘The use of β-blockers after myocardial infarction: no doubts remain’

Article • Nature Reviews Cardiology, January 2026, Springer Science + Business Media

Professor John GF Cleland
Predicting 30-day mortality after hospital admission for heart failure: the National Heart Failure Audit for England and Wales

Article • Heart, January 2026, BMJ

Professor John GF Cleland
Effect of pirfenidone on plasma markers of collagen turnover in patients with heart failure, preserved left ventricular ejection fraction and myocardial fibrosis

Article • Open Heart, January 2026, BMJ

Professor John GF Cleland
Biomarkers of iron deficiency and prognosis in patients hospitalised with new-onset heart failure and a reduced left ventricular ejection fraction

Article • Open Heart, January 2026, BMJ

Professor John GF Cleland
Safely implementing new knowledge from trials of withholding β-blockers after myocardial infarction

Article • Nature Reviews Cardiology, October 2025, Springer Science + Business Media

Professor John GF Cleland
Physiological pacing: mechanisms, clinical indications, and perspectives

Article • European Heart Journal, July 2025, Oxford University Press (OUP)

Professor John GF Cleland
Staring into the AβYSS: how many pills and for how long after myocardial infarction?

Article • European Heart Journal, May 2025, Oxford University Press (OUP)

Professor John GF Cleland
Clinical effectiveness and cost-effectiveness of the rehabilitation enablement in chronic heart failure facilitated self-care rehabilitation intervention for people with heart failure with preserved ejection fraction and their caregivers: rationale and...

Article • BMJ Open, May 2025, BMJ

Professor John GF Cleland, Dr Julia Frost
Macitentan for Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Pulmonary Vascular Disease: Results of the SERENADE Randomized Clinical Trial and Open-Label Extension Study

Article • Circulation Heart Failure, March 2025, Wolters Kluwer Health

Professor John GF Cleland
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial

Article • Heart, February 2025, BMJ

Professor John GF Cleland
Quality of care delivery in patients with acute heart failure: insights from the international REPORT-HF registry

Article • EClinicalMedicine, February 2025, Elsevier

Professor John GF Cleland
Diabetes mellitus is associated with low exercise capacity and impaired peripheral vasodilation in patients with heart failure − a propensity score-matched study

Article • Diabetes Research and Clinical Practice, November 2024, Elsevier

Professor John GF Cleland
Home-Time Is Good, but Feeling Well Is Better. Patient-Journey and Quality Home-Time as End Points in Heart Failure Trials and Registries

Article • Circulation Heart Failure, October 2024, Wolters Kluwer Health

Professor John GF Cleland
Inequalities in access to and outcomes of cardiac surgery in England: retrospective analysis of Hospital Episode Statistics (2010–2019)

Article • Heart, September 2024, BMJ

Professor John GF Cleland
Treating iron deficiency in patients with heart failure: what, why, when, how, where and who

Article • Heart, August 2024, BMJ

Professor John GF Cleland
Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient‐Level Meta‐Analysis

Article • Journal of the American Heart Association, August 2024, Wolters Kluwer Health

Professor John GF Cleland
Breast cancer and heart failure: don’t let the statistics get in the way of the facts

Article • Baylor University Medical Center Proceedings, July 2024, Taylor & Francis

Professor John GF Cleland
Redefining Iron Deficiency in Patients With Chronic Heart Failure

Article • Circulation, July 2024, Wolters Kluwer Health

Professor John GF Cleland
Loop diuretic therapy with or without heart failure: impact on prognosis

Article • European Heart Journal, June 2024, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction

Article • European Heart Journal, May 2024, Oxford University Press (OUP)

Professor John GF Cleland
Inequalities in access to and outcomes of cardiac surgery in England: retrospective analysis of Hospital Episode Statistics (2010-2019)

Article • May 2024, Cold Spring Harbor Laboratory Press

Professor John GF Cleland
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction

Article • Journal of Cardiac Failure, May 2024, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF Trial

Article • Journal of Cardiac Failure, April 2024, Elsevier

Professor John GF Cleland, Dr Joao Pedro Ferreira
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial

Article • European Heart Journal, March 2024, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Withdrawal of renin-angiotensin system inhibitors’ effect on estimated glomerular filtration rate in adults with advanced kidney disease: the STOP-ACEi RCT

Article • Efficacy and Mechanism Evaluation, March 2024, National Institute for Health Research

Professor John GF Cleland
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF

Article • International Journal of Cardiology, March 2024, Elsevier

Professor John GF Cleland
Iron deficiency and supplementation in heart failure

Article • Nature Reviews Cardiology, February 2024, Springer Science + Business Media

Professor John GF Cleland
Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D

Article • International Journal of Cardiology, February 2024, Elsevier

Professor John GF Cleland
Medicines optimization prior to discharge in patients admitted to hospital with heart failure

Article • ESC Heart Failure, January 2024, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
How to diagnose and treat venous congestion in heart failure

Article • European Heart Journal, January 2024, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Article • European Journal of Heart Failure, January 2024, Wiley

Professor Erkin Mirrakhimov, Professor John GF Cleland
Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis

Article • American Heart Journal, January 2024, Elsevier

Professor John GF Cleland
Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease

Article • Kidney International, January 2024, Elsevier

Professor John GF Cleland
Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS‐986231)

Article • European Journal of Heart Failure, December 2023, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study

Article • Clinical Chemistry, December 2023, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study

Article • The Lancet Global Health, December 2023, Elsevier

Professor John GF Cleland
Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and sev...

Article • American Heart Journal, December 2023, Elsevier

Professor John GF Cleland
Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial

Article • ESC Heart Failure, November 2023, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira
Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure

Article • Journal of the American College of Cardiology, November 2023, Elsevier

Professor John GF Cleland
Defining iron deficiency in patients with heart failure

Article • Nature Reviews Cardiology, October 2023, Springer Science + Business Media

Professor John GF Cleland
Phenotype, outcomes and natural history of early‐stage non‐ischaemic cardiomyopathy

Article • European Journal of Heart Failure, October 2023, Wiley

Professor John GF Cleland
Should we resurrect acetazolamide as a diuretic for congestion due to heart failure?

Article • Cardiovascular Research, October 2023, Oxford University Press (OUP)

Professor John GF Cleland
Transportability of two heart failure trials to a disease registry using individual patient data

Article • Journal of Clinical Epidemiology, October 2023, Elsevier

Professor John GF Cleland
Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization

Article • JACC Heart Failure, October 2023, Elsevier

Professor John GF Cleland
Practical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the ESC

Article • European Journal of Heart Failure, September 2023, Wiley

Professor John GF Cleland
Comorbidities and clinical response to cardiac resynchronization therapy: Patient‐level meta‐analysis from eight clinical trials

Article • European Journal of Heart Failure, September 2023, Wiley

Professor John GF Cleland
Effectiveness of out-patient based acute heart failure care: a pilot randomised controlled trial

Article • Acta Cardiologica, September 2023, Taylor & Francis

Professor John GF Cleland
Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry

Article • JACC Heart Failure, September 2023, Elsevier

Professor John GF Cleland
Hospitalization for acute heart failure during non‐working hours impacts on long‐term mortality: the REPORT‐HF registry

Article • ESC Heart Failure, August 2023, Wiley

Professor John GF Cleland
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Article • European Heart Journal, August 2023, Oxford University Press (OUP)

Professor Erkin Mirrakhimov, Professor John GF Cleland
Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus

Article • Clinical Research in Cardiology, August 2023, Springer Science + Business Media

Professor John GF Cleland
Letter regarding the article “Hypocapnia is an independent predictor of in‐hospital mortality in acute heart failure”

Article • ESC Heart Failure, August 2023, Wiley

Professor John GF Cleland
Hospital admissions in the last year of life of patients with heart failure

Article • European Heart Journal - Quality of Care and Clinical Outcomes, August 2023, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Post-COVID-19 illness and associations with sex and gender

Article • BMC Cardiovascular Disorders, August 2023, Springer Science + Business Media

Professor John GF Cleland
Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF

Article • BMJ Open, August 2023, BMJ

Professor John GF Cleland, Dr Joao Pedro Ferreira, Professor Daniel Caldeira
Cardiac resynchronization therapy in patients with a prior history of atrial fibrillation: Insights from four major clinical trials

Article • Journal of Cardiovascular Electrophysiology, July 2023, Wiley

Professor John GF Cleland
Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis

Article • July 2023, Cold Spring Harbor Laboratory Press

Professor John GF Cleland
Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure

Article • ESC Heart Failure, July 2023, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
Coronary revascularization for heart failure with coronary artery disease: A systematic review and meta‐analysis of randomized trials

Article • European Journal of Heart Failure, June 2023, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
Defining Heart Failure Based on Imaging the Heart and Beyond

Article • Cardiac Failure Review, June 2023, Medical Media Communications, Ltd. T/A Radcliffe Cardiology

Dr Pierpaolo Pellicori, Professor John GF Cleland
Variation in optimal hemodynamic atrio‐ventricular delay of biventricular pacing with different endocardial left ventricular lead locations using precision hemodynamics

Article • Journal of Cardiovascular Electrophysiology, May 2023, Wiley

Professor John GF Cleland, Dr Habib Khan
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology

Article • European Journal of Heart Failure, May 2023, Wiley

Professor John GF Cleland
Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease

Article • Heart, May 2023, BMJ

Dr Pierpaolo Pellicori, Professor John GF Cleland
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

Article • Circulation Heart Failure, May 2023, Wolters Kluwer Health

Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira
A machine learning‐derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial

Article • European Journal of Heart Failure, April 2023, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira
Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT‐HF

Article • European Journal of Heart Failure, April 2023, Wiley

Professor John GF Cleland
Urinary Proteomic Signature of Mineralocorticoid Receptor Antagonism by Spironolactone: Evidence from the Randomized-Controlled HOMAGE and PRIORITY Trials

Article • April 2023, Cold Spring Harbor Laboratory Press

Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials

Article • International Journal of Cardiology, April 2023, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira
Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failure

Article • Clinical Research in Cardiology, March 2023, Springer Science + Business Media

Professor John GF Cleland
Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity

Article • Clinical Research in Cardiology, March 2023, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure

Article • Cardiovascular Research, March 2023, Oxford University Press (OUP)

Professor Lutz Schomburg, Professor John GF Cleland
Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis

Article • European Journal of Heart Failure, March 2023, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials

Article • Circulation, March 2023, Wolters Kluwer Health

Professor John GF Cleland
Redefining both iron deficiency and anaemia in cardiovascular disease

Article • European Heart Journal, March 2023, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial)

Article • The American Journal of Cardiology, March 2023, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira
Combining Iron Supplements With SGLT2 Inhibitor-Stimulated Erythropoiesis in Heart Failure: Should We Be Worried About Thromboembolic Events?

Article • Journal of Cardiac Failure, March 2023, Elsevier

Professor John GF Cleland
Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis

Article • ESC Heart Failure, February 2023, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
Effects of haemodynamically atrio‐ventricular optimized His bundle pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) randomized, double‐blind, cross‐over trial

Article • European Journal of Heart Failure, February 2023, Wiley

Professor John GF Cleland
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B‐type natriuretic peptide level: insights from the GALACTIC‐HF trial

Article • European Journal of Heart Failure, January 2023, Wiley

Professor John GF Cleland
Home-based cardiac rehabilitation for people with heart failure and their caregivers: a mixed-methods analysis of the roll out an evidence-based programme in Scotland (SCOT:REACH-HF study)

Article • European Journal of Cardiovascular Nursing, January 2023, Oxford University Press (OUP)

Professor John GF Cleland, Dr Carrie Purcell
The incremental value of multi-organ assessment of congestion using ultrasound in outpatients with heart failure

Article • European Heart Journal - Cardiovascular Imaging, January 2023, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications

Article • Clinical Research in Cardiology, December 2022, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2022, New England Journal of Medicine (NEJM/MMS)

Professor John GF Cleland
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications

Article • Clinical Research in Cardiology, November 2022, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Article • The Lancet, November 2022, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Iron deficiency and cardiovascular disease

Article • European Heart Journal, October 2022, Oxford University Press (OUP)

Professor John GF Cleland
Albuminuria as a marker of systemic congestion in patients with heart failure

Article • European Heart Journal, September 2022, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions

Article • Cardiovascular Research, August 2022, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Rationale and design of a randomised trial of intravenous iron in patients with heart failure

Article • Heart, August 2022, BMJ

Dr Pierpaolo Pellicori, Professor John GF Cleland
An Explainable Transformer-Based Deep Learning Model for the Prediction of Incident Heart Failure

Article • IEEE Journal of Biomedical and Health Informatics, July 2022, Institute of Electrical & Electronics Engineers (IEEE)

Professor John GF Cleland
Dynamic risk stratification using Markov chain modelling in patients with chronic heart failure

Article • ESC Heart Failure, June 2022, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?

Article • European Heart Journal - Quality of Care and Clinical Outcomes, June 2022, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo‐controlled multicentre trial

Article • European Journal of Heart Failure, June 2022, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
Distinct pathophysiological pathways in women and men with heart failure

Article • European Journal of Heart Failure, June 2022, Wiley

Professor John GF Cleland
Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis

Article • JAMA, May 2022, American Medical Association (AMA)

Professor John GF Cleland
Maintaining Public Trust in Medical Advice—Could Less Be More?

Article • JAMA Network Open, May 2022, American Medical Association (AMA)

Professor John GF Cleland
The COVID-19 pandemic and heart failure: lessons from GUIDE-HF

Article • European Heart Journal, May 2022, Oxford University Press (OUP)

Professor John GF Cleland
Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)

Article • European Heart Journal, April 2022, Oxford University Press (OUP)

Professor John GF Cleland
Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction

Article • European Heart Journal, April 2022, Oxford University Press (OUP)

Professor John GF Cleland
Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice

Article • European Journal of Heart Failure, March 2022, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
Synchronized diaphragmatic stimulation: a case report of a novel extra‐cardiac intervention for chronic heart failure

Article • ESC Heart Failure, March 2022, Wiley

Professor John GF Cleland
Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?

Article • Journal of Internal Medicine, February 2022, Wiley

Professor John GF Cleland
Criteria for Iron Deficiency in Patients With Heart Failure

Article • Journal of the American College of Cardiology, February 2022, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?

Article • Thrombosis and Haemostasis, January 2022, Thieme Publishing Group

Professor John GF Cleland
A systematic review and meta-analysis of beta-blockers and renin–angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer

Article • European Heart Journal, December 2021, Oxford University Press (OUP)

Professor John GF Cleland
Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study

Article • European Journal of Heart Failure, December 2021, Wiley

Professor John GF Cleland
Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology

Article • European Heart Journal, December 2021, Oxford University Press (OUP)

Professor John GF Cleland
Myocardial viability testing: all STICHed up, or about to be REVIVED?

Article • European Heart Journal, November 2021, Oxford University Press (OUP)

Professor John GF Cleland
Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis

Article • Clinical Research in Cardiology, September 2021, Springer Science + Business Media

Professor John GF Cleland
The genomics of heart failure: design and rationale of the HERMES consortium

Article • ESC Heart Failure, September 2021, Wiley

Professor John GF Cleland, Marie-Pierre Dubé
A Global Perspective of Racial Differences and Outcomes in Patients Presenting with Acute Heart Failure

Article • American Heart Journal, September 2021, Elsevier

Professor John GF Cleland
To master heart failure, first master congestion

Article • The Lancet, September 2021, Elsevier

Professor John GF Cleland, Dr Pierpaolo Pellicori
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Article • European Heart Journal, August 2021, Oxford University Press (OUP)

Professor John GF Cleland
A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial

Article • ESC Heart Failure, August 2021, Wiley

Professor John GF Cleland
Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study

Article • BMC Medicine, August 2021, Springer Science + Business Media

Professor John GF Cleland
Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial

Article • Cardiovascular Diabetology, August 2021, Springer Science + Business Media

Professor John GF Cleland, Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira
Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure With Reduced Ejection Fraction

Article • Journal of Cardiac Failure, August 2021, Elsevier

Professor John GF Cleland
A novel treatment for heart failure targets myocardial fibrosis

Article • Nature Reports Stem Cells, August 2021, Springer Science + Business Media

Professor John GF Cleland, Dr Pierpaolo Pellicori
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT‐CHF

Article • European Journal of Heart Failure, August 2021, Wiley

Professor John GF Cleland
Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening

Article • BMJ Open Diabetes Research & Care, August 2021, BMJ

Professor John GF Cleland, Dr Pierpaolo Pellicori
Use of Social Media by Cardiovascular Health Care Professionals

Article • JACC Cardiovascular Imaging, August 2021, Elsevier

Professor John GF Cleland, Dr Pierpaolo Pellicori
Reply to the letter regarding the article ‘Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure’

Article • European Journal of Heart Failure, July 2021, Wiley

Professor John GF Cleland, Dr Pierpaolo Pellicori
Stem cell therapy for dilated cardiomyopathy

Article • Cochrane Database of Systematic Reviews, July 2021, Wiley

Professor John GF Cleland, Professor Rienzi A Diaz Navarro
Remote history of VTE is associated with severe COVID‐19 in middle and older age: UK Biobank cohort study

Article • Journal of Thrombosis and Haemostasis, July 2021, Wiley

Professor John GF Cleland, Dr Pierpaolo Pellicori, Dr Evangelia Demou
Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF

Article • Cardiovascular Research, July 2021, Oxford University Press (OUP)

Professor John GF Cleland, Dr Joao Pedro Ferreira
A comparison of non‐invasive methods of measuring body composition in patients with heart failure: a report from SICA‐HF

Article • ESC Heart Failure, July 2021, Wiley

Professor John GF Cleland, Dr Pierpaolo Pellicori
The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart Failure

Article • Journal of Cardiac Failure, July 2021, Elsevier

Professor John GF Cleland
Heart Rate as a Marker of Relapse During Withdrawal of Therapy in Recovered Dilated Cardiomyopathy

Article • JACC Heart Failure, July 2021, Elsevier

Professor John GF Cleland
Identification of sex‐specific biomarkers predicting new‐onset heart failure

Article • ESC Heart Failure, June 2021, Wiley

Professor John GF Cleland, Dr Joao Pedro Ferreira
New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial

Article • Clinical Research in Cardiology, June 2021, Springer Science + Business Media

Professor John GF Cleland, Dr Joao Pedro Ferreira
Association between up‐titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum

Article • European Journal of Heart Failure, June 2021, Wiley

Professor John GF Cleland
Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure

Article • The American Journal of Cardiology, June 2021, Elsevier

Professor John GF Cleland
Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic

Article • European Heart Journal - Quality of Care and Clinical Outcomes, May 2021, Oxford University Press (OUP)

Professor John GF Cleland
Use of diuretics and outcomes in patients with type 2 diabetes: Findings from the EMPA‐REG OUTCOME trial

Article • European Journal of Heart Failure, May 2021, Wiley

Professor John GF Cleland, Dr Pierpaolo Pellicori
Extra‐cardiac targets in the management of cardiometabolic disease: Device‐based therapies

Article • ESC Heart Failure, May 2021, Wiley

Professor John GF Cleland
Non‐adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography‐tandem mass spectrometry (results of a prospective multicentre study)

Article • European Journal of Heart Failure, May 2021, Wiley

Professor John GF Cleland, Dr Dan Lane
Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure

Article • JACC Heart Failure, May 2021, Elsevier

Professor John GF Cleland
Correspondence to European Heart Journal—Quality of Care and Clinical Outcomes in response to paper by Thomas, M. et al. 2021: Predicting the EQ-5D from the Kansas City Cardiomyopathy Questionnaire (KCCQ) in patients with heart failures

Article • European Heart Journal - Quality of Care and Clinical Outcomes, April 2021, Oxford University Press (OUP)

Professor John GF Cleland
Impaired High‐Density Lipoprotein Function in Patients With Heart Failure

Article • Journal of the American Heart Association, April 2021, Wolters Kluwer Health

Professor John GF Cleland
The struggle towards a Universal Definition of Heart Failure—how to proceed?

Article • European Heart Journal, April 2021, Oxford University Press (OUP)

Professor John GF Cleland, Dr Pierpaolo Pellicori
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF

Article • JACC Heart Failure, April 2021, Elsevier

Professor John GF Cleland, Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira
Telomere length is independently associated with all-cause mortality in chronic heart failure

Article • Heart, March 2021, BMJ

Professor John GF Cleland
Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials

Article • Clinical Research in Cardiology, March 2021, Springer Science + Business Media

Professor John GF Cleland, Dr Pierpaolo Pellicori
Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fraction

Article • European Journal of Heart Failure, March 2021, Wiley

Professor John GF Cleland
Prognostic value of the chest X-ray in patients hospitalised for heart failure

Article • Clinical Research in Cardiology, March 2021, Springer Science + Business Media

Professor John GF Cleland, Dr Pierpaolo Pellicori
The value of spot urinary creatinine as a marker of muscle wasting in patients with new‐onset or worsening heart failure

Article • Journal of Cachexia Sarcopenia and Muscle, March 2021, Wiley

Professor John GF Cleland, Dr Pierpaolo Pellicori
The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and ...

Article • European Heart Journal, March 2021, Oxford University Press (OUP)

Professor John GF Cleland
COVID-19 and its cardiovascular effects: a systematic review of prevalence studies

Article • Cochrane Database of Systematic Reviews, March 2021, Wiley

Professor John GF Cleland, Dr Pierpaolo Pellicori
Haemodynamic effects of the nitroxyl donor cimlanod ( BMS ‐986231) in chronic heart failure: a randomized trial

Article • European Journal of Heart Failure, March 2021, Wiley

Professor John GF Cleland
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE

Article • Clinical Research in Cardiology, March 2021, Springer Science + Business Media

Professor John GF Cleland, Dr Joao Pedro Ferreira
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial

Article • European Journal of Heart Failure, March 2021, Wiley

Professor John GF Cleland, Dr Joao Pedro Ferreira
Impact of Geographic Region on the COMMANDER-HF Trial

Article • JACC Heart Failure, March 2021, Elsevier

Professor John GF Cleland, Dr Joao Pedro Ferreira
Temporal trends in heart failure medication prescription in a population-based cohort study

Article • BMJ Open, March 2021, BMJ

Professor John GF Cleland
Pregnancy intention data completeness, quality and utility in population-based surveys: EN-INDEPTH study

Article • Population Health Metrics, February 2021, Springer Science + Business Media

Professor John GF Cleland
Effects of a Novel Nitroxyl Donor in Acute Heart Failure

Article • JACC Heart Failure, February 2021, Elsevier

Professor John GF Cleland, Prof HECTOR BUENO
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2021, New England Journal of Medicine (NEJM/MMS)

Professor John GF Cleland, Professor Vladimir V Rafalskiy
The association between blood groups and COVID‐19 infection: a study from the UK Biobank

Article • Journal of Internal Medicine, January 2021, Wiley

Professor John GF Cleland, Dr Pierpaolo Pellicori
Is acute heart failure a distinctive disorder? An analysis from BIOSTAT‐CHF

Article • European Journal of Heart Failure, January 2021, Wiley

Professor John GF Cleland
Relation Between Thyroid Function and Mortality in Patients With Chronic Heart Failure

Article • The American Journal of Cardiology, January 2021, Elsevier

Professor John GF Cleland
Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED‐HF

Article • European Journal of Heart Failure, December 2020, Wiley

Professor John GF Cleland
Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants

Article • Occupational and Environmental Medicine, December 2020, BMJ

Professor John GF Cleland, Dr Evangelia Demou
High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality

Article • European Journal of Heart Failure, December 2020, Wiley

Professor John GF Cleland
Protocol for an implementation study of an evidence-based home cardiac rehabilitation programme for people with heart failure and their caregivers in Scotland (SCOT:REACH-HF)

Article • BMJ Open, December 2020, BMJ

Professor John GF Cleland, Dr Carrie Purcell
Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure

Article • Circulation Heart Failure, December 2020, Wolters Kluwer Health

Professor John GF Cleland
Ultrasound imaging of congestion in heart failure: examinations beyond the heart

Article • European Journal of Heart Failure, November 2020, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
A current and future outlook on upcoming technologies in remote monitoring of patients with heart failure

Article • European Journal of Heart Failure, November 2020, Wiley

Professor John GF Cleland
Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

Article • Clinical Research in Cardiology, November 2020, Springer Science + Business Media

Professor John GF Cleland
Conduct of Clinical Trials in the Era of COVID-19

Article • Journal of the American College of Cardiology, November 2020, Elsevier

Professor John GF Cleland
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials

Article • European Journal of Heart Failure, October 2020, Wiley

Professor John GF Cleland, Professor Vladimir V Rafalskiy
Plasma D ‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial

Article • European Journal of Heart Failure, October 2020, Wiley

Professor John GF Cleland, Dr Joao Pedro Ferreira
Differences in biomarkers and molecular pathways according to age for patients with HFrEF

Article • Cardiovascular Research, October 2020, Oxford University Press (OUP)

Professor John GF Cleland, Dr Joao Pedro Ferreira
Serum uric acid, influence of sacubitril–valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON‐HF

Article • European Journal of Heart Failure, September 2020, Wiley

Professor John GF Cleland
Muscle wasting as an independent predictor of survival in patients with chronic heart failure

Article • Journal of Cachexia Sarcopenia and Muscle, August 2020, Wiley

Professor John GF Cleland
Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study

Article • The Lancet Global Health, August 2020, Elsevier

Professor John GF Cleland
Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT‐CHF

Article • European Journal of Heart Failure, July 2020, Wiley

Professor John GF Cleland
Structural heart disease, cardiac dysfunction and heart failure: the ambiguity of a definition

Article • European Journal of Preventive Cardiology, July 2020, SAGE Publications

Dr Pierpaolo Pellicori, Professor John GF Cleland
Author Correction: Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease

Article • Nature Reports Stem Cells, July 2020, Springer Science + Business Media

Professor John GF Cleland
Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial

Article • European Journal of Heart Failure, July 2020, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
Artificial Intelligence Needs Clinical Intelligence to Succeed

Article • JACC Heart Failure, July 2020, Elsevier

Professor John GF Cleland
The year in cardiology 2019: heart failure

Article • Romanian Journal of Cardiology, June 2020, Societatea Romana de Cardiologie

Professor John GF Cleland
Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT‐CHF and ASIAN‐HF registries

Article • European Journal of Heart Failure, June 2020, Wiley

Professor John GF Cleland
Home monitoring with technology-supported management in chronic heart failure: a randomised trial

Article • Heart, June 2020, BMJ

Professor John GF Cleland
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

Article • European Heart Journal, June 2020, Oxford University Press (OUP)

Professor John GF Cleland
Caring for people with heart failure and many other medical problems through and beyond the COVID ‐19 pandemic: the advantages of universal access to home telemonitoring

Article • European Journal of Heart Failure, June 2020, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
The year in cardiology: heart failure The year in cardiology 2019

Article • Cardiologia Croatica, June 2020, Medical Publishing, d.o.o.

Professor John GF Cleland
Myocardial injury in severe COVID-19 infection

Article • European Heart Journal, May 2020, Oxford University Press (OUP)

Professor John GF Cleland
Relationship between a single measurement at baseline of body mass index, glycated hemoglobin, and the risk of mortality and cardiovascular morbidity in type 2 diabetes mellitus

Article • Cardiovascular Endocrinology & Metabolism, May 2020, Wolters Kluwer Health

Professor John GF Cleland
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors

Article • European Heart Journal, May 2020, Oxford University Press (OUP)

Professor John GF Cleland
Tumour biomarkers: association with heart failure outcomes

Article • Journal of Internal Medicine, May 2020, Wiley

Professor John GF Cleland
Future research prioritization in cardiac resynchronization therapy

Article • American Heart Journal, May 2020, Elsevier

Professor John GF Cleland
Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial

Article • JACC Heart Failure, May 2020, Elsevier

Professor John GF Cleland
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials

Article • Heart Failure Reviews, April 2020, Springer Science + Business Media

Professor John GF Cleland
Eplerenone prevents an increase in serum carboxy‐terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure

Article • European Journal of Heart Failure, April 2020, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
A network analysis to identify pathophysiological pathways distinguishing ischaemic from non‐ischaemic heart failure

Article • European Journal of Heart Failure, April 2020, Wiley

Professor John GF Cleland
Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure

Article • JAMA Cardiology, April 2020, American Medical Association (AMA)

Professor John GF Cleland
Heart failure treatment up‐titration and outcome and age: an analysis of BIOSTAT‐CHF

Article • European Journal of Heart Failure, March 2020, Wiley

Professor John GF Cleland
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study

Article • The Lancet Global Health, March 2020, Elsevier

Professor John GF Cleland
Predictors of left ventricular remodelling in patients with dilated cardiomyopathy – a cardiovascular magnetic resonance study

Article • European Journal of Heart Failure, February 2020, Wiley

Professor John GF Cleland
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction

Article • Clinical Research in Cardiology, January 2020, Springer Science + Business Media

Professor John GF Cleland
Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study

Article • Clinical Research in Cardiology, January 2020, Springer Science + Business Media

Professor John GF Cleland, Dr Joao Pedro Ferreira
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing ...

Article • European Journal of Heart Failure, January 2020, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira
The year in cardiology: heart failure

Article • European Heart Journal, January 2020, Oxford University Press (OUP)

Professor John GF Cleland
OUP accepted manuscript

Article • European Heart Journal, January 2020, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira
Chronic Obstructive Pulmonary Disease and Heart Failure

Article • Heart Failure Clinics, January 2020, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006–2015

Article • European Heart Journal, December 2019, Oxford University Press (OUP)

Professor John GF Cleland
What do patients with heart failure die from? A single assassin or a conspiracy?

Article • European Journal of Heart Failure, December 2019, Wiley

Professor John GF Cleland
Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank

Article • Diabetes Care, December 2019, American Diabetes Association

Professor John GF Cleland
Selenium and outcome in heart failure

Article • European Journal of Heart Failure, December 2019, Wiley

Professor John GF Cleland
Clinical value of pre‐discharge bio‐adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission

Article • European Journal of Heart Failure, December 2019, Wiley

Professor John GF Cleland
Cardiovascular and non‐cardiovascular death distinction: the utility of troponin beyond N‐terminal pro‐B‐type natriuretic peptide. Findings from the BIOSTAT‐CHF study

Article • European Journal of Heart Failure, December 2019, Wiley

Dr Joao Pedro Ferreira, Professor John GF Cleland
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure

Article • Journal of the American College of Cardiology, December 2019, Elsevier

Professor John GF Cleland
Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets

Article • European Journal of Heart Failure, November 2019, Wiley

Professor John GF Cleland
Association of Fitness and Grip Strength With Heart Failure

Article • Mayo Clinic Proceedings, November 2019, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF

Article • European Journal of Internal Medicine, November 2019, Elsevier

Dr Joao Pedro Ferreira, Professor John GF Cleland
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease

Article • Nature Reports Stem Cells, November 2019, Springer Science + Business Media

Professor John GF Cleland
Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality

Article • JACC Heart Failure, November 2019, Elsevier

Professor John GF Cleland
Temporal Trends and Patterns in Mortality After Incident Heart Failure

Article • JAMA Cardiology, November 2019, American Medical Association (AMA)

Professor John GF Cleland
Trajectories of Changes in Renal Function in Patients with Acute Heart Failure

Article • Journal of Cardiac Failure, November 2019, Elsevier

Professor John GF Cleland
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2019, New England Journal of Medicine (NEJM/MMS)

Professor Vladimir V Rafalskiy, Professor John GF Cleland
Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: A systematic review and meta‐analysis

Article • Annals of Noninvasive Electrocardiology, October 2019, Wiley

Professor John GF Cleland
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study

Article • The Lancet, October 2019, Elsevier

Professor John GF Cleland
Stem cell.

Article • Cochrane Database of Systematic Reviews, September 2019, Wiley

Professor Rienzi A Diaz Navarro, Professor John GF Cleland
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology

Article • European Journal of Heart Failure, August 2019, Wiley

Professor John GF Cleland
Effects of Serelaxin in Patients with Acute Heart Failure

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2019, New England Journal of Medicine (NEJM/MMS)

Professor John GF Cleland
Implantable device monitoring versus usual care for managing individuals with heart failure

Article • Cochrane Database of Systematic Reviews, August 2019, Wiley

Professor John GF Cleland
Myocardial Dysfunction and Coronary Artery Disease as Therapeutic Targets in Heart Failure

Article • Circulation, August 2019, Wolters Kluwer Health

Dr Pierpaolo Pellicori, Professor John GF Cleland
Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease

Article • Circulation, August 2019, Wolters Kluwer Health

Professor John GF Cleland
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?

Article • European Heart Journal, August 2019, Oxford University Press (OUP)

Professor John GF Cleland
Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo‐controlled trial

Article • ESC Heart Failure, August 2019, Wiley

Professor John GF Cleland
Prevalence and Incidence of Atrial Fibrillation in Ambulatory Patients with Heart Failure

Article • The American Journal of Cardiology, August 2019, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure – A multicenter propensity score matched analysis

Article • International Journal of Cardiology, August 2019, Elsevier

Professor John GF Cleland
Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement

Article • JACC Cardiovascular Imaging, August 2019, Elsevier

Professor John GF Cleland
Geographical location affects the levels and association of trimethylamine N‐oxide with heart failure mortality in BIOSTAT‐CHF: a post‐hoc analysis

Article • European Journal of Heart Failure, July 2019, Wiley

Professor John GF Cleland
High sensitivity C-Reactive Protein in Chronic Heart Failure: Patient Characteristics, Phenotypes and Mode of Death

Article • Cardiovascular Research, July 2019, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy

Article • Heart, July 2019, BMJ

Professor John GF Cleland
New perspectives and future directions in the treatment of heart failure

Article • Heart Failure Reviews, July 2019, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

Article • Clinical Research in Cardiology, July 2019, Springer Science + Business Media

Professor John GF Cleland
Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure

Article • JAMA Cardiology, July 2019, American Medical Association (AMA)

Professor John GF Cleland
When can heart failure treatment be stopped safely? – Authors' reply

Article • The Lancet, July 2019, Elsevier

Professor John GF Cleland
The shocking lack of evidence for implantable cardioverter defibrillators for heart failure; with or without cardiac resynchronization

Article • European Heart Journal, June 2019, Oxford University Press (OUP)

Professor John GF Cleland
A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial

Article • European Heart Journal, June 2019, Oxford University Press (OUP)

Dr Joao Pedro Ferreira, Professor John GF Cleland
Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure

Article • European Journal of Heart Failure, June 2019, Wiley

Professor John GF Cleland
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Article • Kidney International, June 2019, Elsevier

Dr Debasish Banerjee, Professor John GF Cleland
Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm

Article • JAMA Cardiology, June 2019, American Medical Association (AMA)

Professor John GF Cleland
Characteristics and outcome of acute heart failure patients according to the severity of peripheral oedema

Article • International Journal of Cardiology, June 2019, Elsevier

Professor John GF Cleland
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

Article • European Journal of Heart Failure, June 2019, Wiley

Professor John GF Cleland
Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients

Article • PLoS Medicine, May 2019, PLOS

Professor John GF Cleland
The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study

Article • European Journal of Heart Failure, May 2019, Wiley

Professor John GF Cleland
Erratum to ‘The role of angiotensin receptor–neprilysin inhibitors in cardiovascular disease—existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963–972]

Article • European Journal of Heart Failure, May 2019, Wiley

Professor John GF Cleland
Prevention or Procrastination for Heart Failure?

Article • Journal of the American College of Cardiology, May 2019, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure

Article • Circulation Heart Failure, May 2019, Wolters Kluwer Health

Dr Joao Pedro Ferreira, Professor John GF Cleland
The rise and fall of aspirin in the primary prevention of cardiovascular disease

Article • The Lancet, May 2019, Elsevier

Professor John GF Cleland, Professor Deepak L Bhatt
Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit

Article • Clinical Research in Cardiology, April 2019, Springer Science + Business Media

Professor John GF Cleland
Clinical and prognostic association of total atrial conduction time in patients with heart failure

Article • Journal of Cardiovascular Medicine, April 2019, Wolters Kluwer Health

Dr Pierpaolo Pellicori, Professor John GF Cleland
Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost–utility analyses

Article • Heart Failure Reviews, March 2019, Springer Science + Business Media

Professor John GF Cleland
Bio‐adrenomedullin as a marker of congestion in patients with new‐onset and worsening heart failure

Article • European Journal of Heart Failure, March 2019, Wiley

Professor John GF Cleland
Added value of frailty and social support in predicting risk of 30-day unplanned re-admission or death for patients with heart failure: An analysis from OPERA-HF

Article • International Journal of Cardiology, March 2019, Elsevier

Professor John GF Cleland
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe

Article • Heart, February 2019, BMJ

Professor John GF Cleland
The year in cardiology 2018: heart failure

Article • European Heart Journal, February 2019, Oxford University Press (OUP)

Professor John GF Cleland
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology

Article • European Journal of Heart Failure, February 2019, Wiley

Professor John GF Cleland, Manuel Mayr
Burden of medical co‐morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy

Article • European Journal of Heart Failure, January 2019, Wiley

Professor John GF Cleland
Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure

Article • European Journal of Heart Failure, January 2019, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation

Article • Clinical Research in Cardiology, January 2019, Springer Science + Business Media

Professor John GF Cleland
Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study

Article • European Journal of Heart Failure, January 2019, Wiley

Dr Joao Pedro Ferreira, Professor John GF Cleland
Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure: A multi-centre efficacy study using the Reitan Catheter Pump (RCP)

Article • International Journal of Cardiology, January 2019, Elsevier

Professor John GF Cleland
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial

Article • The Lancet, January 2019, Elsevier

Professor John GF Cleland
Novel endotypes in heart failure: effects on guideline-directed medical therapy

Article • European Heart Journal, December 2018, Oxford University Press (OUP)

Professor John GF Cleland
Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin

Article • Indian Heart Journal, December 2018, Elsevier

Professor John GF Cleland
Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure

Article • Clinical Proteomics, November 2018, Springer Science + Business Media

Professor John GF Cleland
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction

Article • International Journal of Cardiology, November 2018, Elsevier

Professor John GF Cleland
Linee guida ESC/ESH 2018 per la diagnosi e il trattamento dell’ipertensione arteriosa. Task Force per la Diagnosi e il Trattamento dell’Ipertensione Arteriosa della Società Europea di Cardiologia (ESC) e della Società Europea dell’Ipertensione Arterios...

Article • Giornale Italiano di Cardiologia, November 2018, Il Pensiero Scientifico Editore

Professor John GF Cleland
Association with outcomes and response to treatment of trimethylamine N‐oxide in heart failure: results from BIOSTAT‐CHF

Article • European Journal of Heart Failure, October 2018, Wiley

Professor John GF Cleland
Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from the First Euro Heart Failure Survey

Article • Clinical Research in Cardiology, October 2018, Springer Science + Business Media

Professor John GF Cleland
Treatments targeting inotropy

Article • European Heart Journal, October 2018, Oxford University Press (OUP)

Professor Dietmar J. Manstein, Professor John GF Cleland
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2018, New England Journal of Medicine (NEJM/MMS)

Professor John GF Cleland
Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure

Article • International Journal of Cardiology, October 2018, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial

Article • JAMA Cardiology, October 2018, American Medical Association (AMA)

Professor John GF Cleland
Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart Failure

Article • Circulation Cardiovascular Imaging, September 2018, Wolters Kluwer Health

Professor John GF Cleland
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction

Article • Journal of the American College of Cardiology, September 2018, Elsevier

Professor John GF Cleland
Telehealth: delivering high-quality care for heart failure

Article • The Lancet, September 2018, Elsevier

Professor John GF Cleland
2018 ESC/ESH Guidelines for the management of arterial hypertension

Article • European Heart Journal, August 2018, Oxford University Press (OUP)

Professor marija B Vavlukis, Prof HECTOR BUENO, Professor John GF Cleland, Salim Benkhedda
Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction

Article • European Heart Journal, August 2018, Oxford University Press (OUP)

Professor John GF Cleland
Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure

Article • Heart, August 2018, BMJ

Dr Joao Pedro Ferreira, Professor John GF Cleland
Mortality after admission for heart failure in the UK compared with Japan

Article • Open Heart, August 2018, BMJ

Professor John GF Cleland
Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life

Article • Clinical Research in Cardiology, July 2018, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
Prevalence and determinants of hypertension in apparently healthy schoolchildren in India: A multi-center study

Article • European Journal of Preventive Cardiology, July 2018, SAGE Publications

Professor John GF Cleland
Role of immunomodulation on heart functiom following heart attack

Article • Cardiovascular Research, July 2018, Oxford University Press (OUP)

Dr Habib Khan, Professor John GF Cleland
Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial

Article • ESC Heart Failure, July 2018, Wiley

Professor John GF Cleland
Methodological Shortcomings of Wrist-Worn Heart Rate Monitors Validations

Article • Journal of Medical Internet Research, July 2018, JMIR Publications Inc.

Professor John GF Cleland
Waist-to-hip ratio and mortality in heart failure

Article • European Journal of Heart Failure, July 2018, Wiley

Professor John GF Cleland
Losing Track by Tracking Speckles

Article • JACC Cardiovascular Imaging, July 2018, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial

Article • Circulation Heart Failure, July 2018, Wolters Kluwer Health

Professor John GF Cleland
Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis

Article • Clinical Research in Cardiology, June 2018, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
Psychosocial factors and mortality in patients with heart failure: reply

Article • European Journal of Heart Failure, June 2018, Wiley

Professor John GF Cleland
Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy

Article • European Journal of Heart Failure, June 2018, Wiley

Professor John GF Cleland
Prevalence and Prognostic Significance of Malnutrition Using 3 Scoring Systems Among Outpatients With Heart Failure

Article • JACC Heart Failure, June 2018, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and Japan

Article • European Journal of Heart Failure, May 2018, Wiley

Professor John GF Cleland
Outcome of hospitalised heart failure in Japan and the United Kingdom stratified by plasma N-terminal pro-B-type natriuretic peptide

Article • Clinical Research in Cardiology, May 2018, Springer Science + Business Media

Professor John GF Cleland
Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey)

Article • The American Journal of Cardiology, May 2018, Elsevier

Dr. Elton AMP Dudink, Professor John GF Cleland
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure

Article • International Journal of Cardiology, May 2018, Elsevier

Professor John GF Cleland
Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion

Article • Circulation Heart Failure, May 2018, Wolters Kluwer Health

Professor John GF Cleland
Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF

Article • Clinical Research in Cardiology, March 2018, Springer Science + Business Media

Professor John GF Cleland
Acute heart failure: lessons learned, roads ahead

Article • European Journal of Heart Failure, March 2018, Wiley

Prof HECTOR BUENO, Professor John GF Cleland
An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors

Article • BMJ Open, March 2018, BMJ

Professor John GF Cleland
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes

Article • European Journal of Heart Failure, February 2018, Wiley

Professor John GF Cleland
The role of angiotensin receptor–neprilysin inhibitors in cardiovascular disease—existing evidence, knowledge gaps, and future directions

Article • European Journal of Heart Failure, February 2018, Wiley

Professor John GF Cleland
CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how?

Article • European Journal of Heart Failure, February 2018, Wiley

Professor John GF Cleland
Methodological Shortcomings of Wrist-Worn Heart Rate Monitors Validations (Preprint)

Article • February 2018, JMIR Publications Inc.

Professor John GF Cleland
Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion

Article • European Journal of Heart Failure, February 2018, Wiley

Professor John GF Cleland
Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF

Article • European Journal of Heart Failure, January 2018, Wiley

Professor John GF Cleland
Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study

Article • European Journal of Heart Failure, January 2018, Wiley

Dr Pierpaolo Pellicori, Professor John GF Cleland
The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis

Article • European Journal of Heart Failure, January 2018, Wiley

Professor John GF Cleland
Estimated peak functional capacity: an accurate method for assessing change in peak oxygen consumption after cardiac rehabilitation?

Article • Clinical Physiology and Functional Imaging, August 2017, Wiley

Dr simon nichols, Professor John GF Cleland
Coronary angiography in worsening heart failure: determinants, findings and prognostic implications

Article • Heart, August 2017, BMJ

Dr Joao Pedro Ferreira, Professor John GF Cleland
Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study

Article • European Heart Journal - Cardiovascular Pharmacotherapy, May 2017, Oxford University Press (OUP)

Professor John GF Cleland
An m-Health system for education and motivation in cardiac rehabilitation: the experience of HeartCycle guided exercise

Article • Journal of Telemedicine and Telecare, March 2017, SAGE Publications

Dario Salvi, Professor John GF Cleland
Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS

Article • Journal of Cardiac Failure, October 2016, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients

Article • International Journal of Cardiology, February 2016, Elsevier

Professor John GF Cleland
MicroRNAs relate to early worsening of renal function in patients with acute heart failure

Article • International Journal of Cardiology, January 2016, Elsevier

Professor John GF Cleland
Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction

Article • European Journal of Heart Failure, December 2015, Wiley

Professor john j mcmurray, Professor John GF Cleland
Plasma kidney injury molecule‐1 in heart failure: renal mechanisms and clinical outcome

Article • European Journal of Heart Failure, October 2015, Wiley

Professor John GF Cleland
A personalised mobile-based home monitoring system for heart failure: The SUPPORT-HF Study

Article • International Journal of Medical Informatics, October 2015, Elsevier

Dr Andreas K Triantafyllidis, Professor John GF Cleland
A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model

Article • Heart Rhythm, October 2015, Elsevier

Professor John GF Cleland
Hydralazine and nitrates alone or combined for the management of chronic heart failure: A systematic review

Article • International Journal of Cardiology, October 2015, Elsevier

Professor John GF Cleland, Professor Ashraf Fawzy Nabhan
Abordaje multidisciplinario en pacientes hospitalizados por insuficiencia cardiaca

Article • Revista Española de Cardiología, October 2015, Elsevier

Professor John GF Cleland
Should β-Blockers Be Used in Patients With Heart Failure and Atrial Fibrillation?

Article • Clinical Therapeutics, October 2015, Elsevier

Professor John GF Cleland
Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial

Article • Nephrology Dialysis Transplantation, September 2015, Oxford University Press (OUP)

Professor John GF Cleland
Signature of circulating microRNAs in patients with acute heart failure

Article • European Journal of Heart Failure, September 2015, Wiley

Professor John GF Cleland
Development of a Human Model for the Study of Effects of Hypoxia, Exercise, and Sildenafil on Cardiac and Vascular Function in Chronic Heart Failure

Article • Journal of Cardiovascular Pharmacology, September 2015, Wolters Kluwer Health

Professor John GF Cleland
Cardiac Resynchronization Therapy Update: Evolving Indications, Expanding Benefit?

Article • Current Cardiology Reports, August 2015, Springer Science + Business Media

Professor John GF Cleland
Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Article • PLOS One, August 2015, PLOS

Professor john j mcmurray, Professor John GF Cleland
A combined clinical and biomarker approach to predict diuretic response in acute heart failure

Article • Clinical Research in Cardiology, August 2015, Springer Science + Business Media

Professor John GF Cleland
Adherence to self-care in patients with heart failure in the HeartCycle study

Article • Patient Preference and Adherence, August 2015, Taylor & Francis

Professor John GF Cleland
QRS morphology as a predictor of the response to cardiac resynchronisation therapy: fact or fashion?

Article • Heart, July 2015, BMJ

Professor John GF Cleland
Reflections on EchoCRT: sound guidance on QRS duration and morphology for CRT?: Figure 1

Article • European Heart Journal, July 2015, European Society of Cardiology

Professor John GF Cleland
Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial

Article • European Journal of Heart Failure, June 2015, Wiley

Dr Robert John Mentz, Professor John GF Cleland
Heart failure with preserved ejection fraction: uncertainties and dilemmas

Article • European Journal of Heart Failure, June 2015, Wiley

Professor John GF Cleland
Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro–B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction

Article • JACC Heart Failure, June 2015, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure

Article • Heart, May 2015, BMJ

Dr Pierpaolo Pellicori, Professor John GF Cleland
The Obesity Paradox in Type 2 Diabetes Mellitus: Relationship of Body Mass Index to Prognosis

Article • Annals of Internal Medicine, May 2015, American College of Physicians

Dr Pierpaolo Pellicori, Professor John GF Cleland
Worsening Heart Failure Following Admission for Acute Heart Failure

Article • JACC Heart Failure, May 2015, Elsevier

Professor John GF Cleland
Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and si...

Article • European Journal of Heart Failure, April 2015, Wiley

Dr Roger M Mills, Professor John GF Cleland
The relationship of QRS morphology with cardiac structure and function in patients with heart failure

Article • Clinical Research in Cardiology, April 2015, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most?

Article • European Heart Journal, April 2015, European Society of Cardiology

Professor John GF Cleland
When Is it Appropriate to Withdraw Cardiac Resynchronization Therapy? Guesses and Evidence ∗

Article • JACC Heart Failure, April 2015, Elsevier

Professor John GF Cleland
If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment?

Article • Journal of Telemedicine and Telecare, March 2015, SAGE Publications

Dr Pierpaolo Pellicori, Professor John GF Cleland
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT‐HF): rationale for and design of a global registry

Article • European Journal of Heart Failure, March 2015, Wiley

Professor John GF Cleland
Update on management of heart failure with preserved ejection fraction

Article • Current Opinion in Cardiology, March 2015, Wolters Kluwer Health

Dr Pierpaolo Pellicori, Professor John GF Cleland
Prescribing Patterns to Optimize Heart Rate

Article • JACC Heart Failure, March 2015, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Is the Epidemic of Heart Disease Really Over or Just Evolving?

Article • The American Journal of Medicine, March 2015, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Acute Heart Failure in the Elderly: Differences in Clinical Characteristics, Outcomes, and Prognostic Factors in the VERITAS Study

Article • Journal of Cardiac Failure, March 2015, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Bone marrow iron depletion is common in patients with coronary artery disease

Article • International Journal of Cardiology, March 2015, Elsevier

Professor John GF Cleland
The Effect of Carvedilol on B-Type Natriuretic Peptide and Cardiac Function in Patients with Heart Failure and Persistent Atrial Fibrillation

Article • Cardiology, January 2015, Karger Publishers

Professor John GF Cleland
Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

Article • European Journal of Heart Failure, December 2014, Wiley

Professor john j mcmurray, Professor John GF Cleland
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis

Article • The Lancet, December 2014, Elsevier

Professor Giuseppe M C Rosano, Professor John GF Cleland
Breathlessness at rest is not the dominant presentation of patients admitted with heart failure

Article • European Journal of Heart Failure, November 2014, Wiley

Professor John GF Cleland
Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial

Article • European Journal of Heart Failure, November 2014, Wiley

Professor Marco Metra, Professor John GF Cleland
European Cardiac Resynchronization Therapy Survey II: rationale and design

Article • EP Europace, November 2014, European Society of Cardiology

Professor John GF Cleland
Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study

Article • European Journal of Heart Failure, November 2014, Wiley

Professor john j mcmurray, Professor John GF Cleland
Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value

Article • European Heart Journal, October 2014, European Society of Cardiology

Dr Pierpaolo Pellicori, Professor John GF Cleland
Charting a Roadmap for Heart Failure Biomarker Studies

Article • JACC Heart Failure, October 2014, Elsevier

Dr Robert John Mentz, Professor John GF Cleland
Lipid-Modifying Treatments for Heart Failure

Article • Heart Failure Clinics, October 2014, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Does Speckle Tracking Really Improve Diagnosis and Risk Stratification in Patients With HF With Normal EF?

Article • Journal of the American College of Cardiology, October 2014, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Classification of a real live heart failure clinical dataset- Is TAN Bayes better than other Bayes?

Article • October 2014, Institute of Electrical & Electronics Engineers (IEEE)

Professor John GF Cleland
Heart ‘omics’ in AGEing (HOMAGE): design, research objectives and characteristics of the common database

Article • Journal of Biomedical Research, September 2014, Journal of Biomedical Research

Professor John GF Cleland
Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Article • European Heart Journal, September 2014, European Society of Cardiology

Professor john j mcmurray, Professor John GF Cleland
Is the Way to a Man’s Heart Through His Stomach?

Article • Journal of the American College of Cardiology, September 2014, Elsevier

Professor John GF Cleland
Exercise Capacity and Mortality in Patients With Ischemic Left Ventricular Dysfunction Randomized to Coronary Artery Bypass Graft Surgery or Medical Therapy

Article • JACC Heart Failure, August 2014, Elsevier

Professor John GF Cleland
The utility of novel non-invasive technologies for remote hemodynamic monitoring in chronic heart failure

Article • Expert Review of Cardiovascular Therapy, July 2014, Taylor & Francis

Professor John GF Cleland
Remote telemonitoring for patients with heart failure: might monitoring pulmonary artery pressure become routine?

Article • Expert Review of Cardiovascular Therapy, July 2014, Taylor & Francis

Dr Pierpaolo Pellicori, Professor John GF Cleland
Clinical Trials in Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction

Article • Heart Failure Clinics, July 2014, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Use of cumulative information estimations for risk assessment of heart failure patients

Article • July 2014, Institute of Electrical & Electronics Engineers (IEEE)

Professor John GF Cleland
Telemonitoring in heart failure: Big Brother watching over you

Article • Heart Failure Reviews, June 2014, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure

Article • European Heart Journal, June 2014, European Society of Cardiology

Professor John GF Cleland
The remarkable effect of ivabradine in two adolescents with dilated cardiomyopathy

Article • Clinical Research in Cardiology, June 2014, Springer Science + Business Media

Professor John GF Cleland
Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations

Article • JACC Heart Failure, June 2014, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Is Heart Rate Important for Patients With Heart Failure in Atrial Fibrillation?

Article • JACC Heart Failure, June 2014, Elsevier

Professor John GF Cleland
The relation between repeated 6-minute walk test performance and outcome in patients with chronic heart failure

Article • Annals of Physical and Rehabilitation Medicine, June 2014, Elsevier

Professor John GF Cleland
International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial

Article • European Journal of Heart Failure, April 2014, Wiley

Dr Robert John Mentz, Professor John GF Cleland
Developing Therapies for Heart Failure With Preserved Ejection Fraction

Article • JACC Heart Failure, April 2014, Elsevier

Professor Giuseppe M C Rosano, Professor john j mcmurray, Professor John GF Cleland
Fatigue as a Predictor of Outcome in Patients With Heart Failure

Article • JACC Heart Failure, April 2014, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Issues in the Mining of Heart Failure Datasets

Article • International Journal of Automation and Computing, April 2014, Springer Science + Business Media

Professor John GF Cleland
Is age a factor in the success or failure of remote monitoring in heart failure? Telemonitoring and structured telephone support in elderly heart failure patients

Article • European Journal of Cardiovascular Nursing, March 2014, SAGE Publications

Professor John GF Cleland
Xanthine Oxidase Inhibition for the Treatment of Cardiovascular Disease: A Systematic Review and Meta-Analysis

Article • Cardiovascular Therapeutics, March 2014, Wiley

Professor John GF Cleland
Decongestion in acute heart failure

Article • European Journal of Heart Failure, March 2014, Oxford University Press (OUP)

Dr Robert John Mentz, Professor John GF Cleland
Aspirin for Heart Failure

Article • Circulation Heart Failure, March 2014, Wolters Kluwer Health

Professor John GF Cleland
Diuretic response in acute heart failure: clinical characteristics and prognostic significance

Article • European Heart Journal, February 2014, European Society of Cardiology

Professor Adriaan A Voors, Professor John GF Cleland
Development of a composite model derived from cardiopulmonary exercise tests to predict mortality risk in patients with mild-to-moderate heart failure

Article • Heart, February 2014, BMJ

Professor John GF Cleland
Thyroid-Stimulating Hormone and Clinical Outcomes

Article • JACC Heart Failure, February 2014, Elsevier

Professor john j mcmurray, Professor John GF Cleland
The in vitro stability of novel cardiovascular and sepsis biomarkers at ambient temperature

Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2014, De Gruyter

Dr Pierpaolo Pellicori, Professor John GF Cleland
Revisiting a classical clinical sign: Jugular venous ultrasound

Article • International Journal of Cardiology, January 2014, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Guía de práctica clínica de la ESC 2013 sobre estimulación cardiaca y terapia de resincronización cardiaca

Article • Revista Española de Cardiología, January 2014, Elsevier

Professor John GF Cleland
Definitions of Outcome, Response and Effect in Imaging Research to Avoid Confusion

Article • JACC Cardiovascular Imaging, January 2014, Elsevier

Professor John GF Cleland
Predictors of Postdischarge Outcomes From Information Acquired Shortly After Admission for Acute Heart Failure

Article • Circulation Heart Failure, January 2014, Wolters Kluwer Health

Professor John GF Cleland
Renal Function Trajectories and Clinical Outcomes in Acute Heart Failure

Article • Circulation Heart Failure, January 2014, Wolters Kluwer Health

Professor John GF Cleland
The Long-Term Prognostic Significance of 6-Minute Walk Test Distance in Patients with Chronic Heart Failure

Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

Professor John GF Cleland
Impact of aspirin and statins on long-term survival in patients hospitalized with acute myocardial infarction complicated by heart failure: an analysis of 1706 patients

Article • European Journal of Heart Failure, December 2013, Wiley

Professor John GF Cleland
Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties

Article • European Journal of Heart Failure, December 2013, Wiley

Professor Giuseppe M C Rosano, Professor John GF Cleland
Sex-specific acute heart failure phenotypes and outcomes from PROTECT

Article • European Journal of Heart Failure, December 2013, Wiley

Professor John GF Cleland
The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE)

Article • Journal of the American College of Cardiology, December 2013, Elsevier

Professor John GF Cleland
Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification?

Article • The International Journal of Cardiovascular Imaging, October 2013, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
Iron Status and Survival in Diabetic Patients With Coronary Artery Disease

Article • Diabetes Care, October 2013, American Diabetes Association

Professor John GF Cleland
Case Selection for Cardiac Resynchronization in Atrial Fibrillation

Article • Heart Failure Clinics, October 2013, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

Article • European Journal of Heart Failure, October 2013, Wiley

Professor Giuseppe M C Rosano, Professor john j mcmurray, Professor John GF Cleland
Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure

Article • International Journal of Cardiology, October 2013, Elsevier

Professor john j mcmurray, Professor John GF Cleland
The effectiveness of enhanced external counterpulsation (EECP) in patients suffering from chronic refractory angina previously treated with transmyocardial laser revascularisation

Article • International Journal of Cardiology, October 2013, Elsevier

Professor John GF Cleland
Wytyczne ESC dotyczące stymulacji serca i terapii resynchronizującej w 2013 roku

Article • Kardiologia Polska, September 2013, Polskie Towarzystwo Kardiologiczne

Professor John GF Cleland
Diabetes, aliskiren, and heart failure: let's bring ASTRONAUT down to earth

Article • European Heart Journal, September 2013, European Society of Cardiology

Professor John GF Cleland
Hypoglycaemia in diabetic patients: highly undesirable by cardiologists

Article • European Heart Journal, September 2013, European Society of Cardiology

Professor John GF Cleland
Does cirrhotic cardiomyopathy exist? 50 years of uncertainty

Article • Clinical Research in Cardiology, September 2013, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
Not all systematic reviews are systematic: a meta-review of the quality of systematic reviews for non-invasive remote monitoring in heart failure

Article • Journal of Telemedicine and Telecare, September 2013, SAGE Publications

Professor John GF Cleland
Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs

Article • BMJ Open, September 2013, BMJ

Professor John GF Cleland
Is aspirin useful in primary prevention?

Article • European Heart Journal, August 2013, European Society of Cardiology

Professor John GF Cleland
Digoxin Reduces 30-day All-cause Hospital Admission in Older Patients with Chronic Systolic Heart Failure

Article • The American Journal of Medicine, August 2013, Elsevier

Professor john j mcmurray, Dr. Richard M Allman, Professor John GF Cleland
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure

Article • European Heart Journal, July 2013, European Society of Cardiology

Professor John GF Cleland
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

Article • European Heart Journal, June 2013, European Society of Cardiology

Professor Luigi P. Badano, Prof HECTOR BUENO, Professor John GF Cleland
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associati...

Article • EP Europace, June 2013, European Society of Cardiology

Prof HECTOR BUENO, Professor Luigi P. Badano, Professor John GF Cleland
Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis

Article • Heart, May 2013, BMJ

Professor John GF Cleland
Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial

Article • European Journal of Heart Failure, May 2013, Wiley

Professor john j mcmurray, Professor John GF Cleland
Effects of reducing inspired oxygen concentration for one hour in patients with chronic heart failure: implications for air travel

Article • European Journal of Heart Failure, May 2013, Wiley

Professor John GF Cleland
Improving Quality of Life and Functional Capacity in Atrial Fibrillation and Congestive Heart Failure

Article • Journal of the American College of Cardiology, May 2013, Elsevier

Professor John GF Cleland
Influence of Crossover on Mortality in a Randomized Study of Revascularization in Patients With Systolic Heart Failure and Coronary Artery Disease

Article • Circulation Heart Failure, May 2013, Wolters Kluwer Health

Professor John GF Cleland
Interplay Between Right Ventricular Function and Cardiac Resynchronization Therapy

Article • Journal of the American College of Cardiology, May 2013, Elsevier

Professor John GF Cleland
The Predictive Value of Short-Term Changes in Hemoglobin Concentration in Patients Presenting With Acute Decompensated Heart Failure

Article • Journal of the American College of Cardiology, May 2013, Elsevier

Professor John GF Cleland
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial

Article • European Heart Journal, April 2013, European Society of Cardiology

Professor John GF Cleland
Why Does CRT Reduce the Risk of Arrhythmias?

Article • JACC Cardiovascular Imaging, April 2013, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Renal Sympathetic Denervation Therapy for Resistant Hypertension

Article • Circulation Cardiovascular Interventions, April 2013, Wolters Kluwer Health

Professor John GF Cleland, Professor Deepak L Bhatt
Fish Oil vs Olive Oil for Postoperative Atrial Fibrillation

Article • JAMA, March 2013, American Medical Association (AMA)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Repeat Dose Opioids May Be Effective for Breathlessness in Chronic Heart Failure if Given for Long Enough

Article • Journal of Palliative Medicine, March 2013, Mary Ann Liebert Inc

Professor John GF Cleland
Defining Diastolic Heart Failure and Identifying Effective Therapies

Article • JAMA, February 2013, American Medical Association (AMA)

Dr Pierpaolo Pellicori, Professor John GF Cleland
Medical Management of Stable Coronary Atherosclerosis

Article • Current Atherosclerosis Reports, February 2013, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
Identifying patients at risk of death or hospitalisation due to worsening heart failure using decision tree analysis: Evidence from the Trans-European Network-Home-Care Management System (TEN-HMS) Study

Article • International Journal of Cardiology, February 2013, Elsevier

Professor John GF Cleland
Causes and treatment of oedema in patients with heart failure

Article • Nature Reviews Cardiology, January 2013, Springer Science + Business Media

Professor John GF Cleland
A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure

Article • Journal of the American College of Cardiology, January 2013, Elsevier

Professor Giuseppe M C Rosano, Professor John GF Cleland
IVC Diameter in Patients With Chronic Heart Failure

Article • JACC Cardiovascular Imaging, January 2013, Elsevier

Dr Pierpaolo Pellicori, Professor John GF Cleland
Sildenafil in Heart Failure (SilHF). An investigator-initiated multinational randomized controlled clinical trial: rationale and design

Article • European Journal of Heart Failure, January 2013, Wiley

Professor John GF Cleland
Soluble Glycoprotein 130 Predicts Fatal Outcomes in Chronic Heart Failure: Analysis From the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Article • Circulation Heart Failure, December 2012, Wolters Kluwer Health

Professor john j mcmurray, Professor John GF Cleland
Influence of step length on 6-minute walk test performance in patients with chronic heart failure

Article • Physiotherapy, December 2012, Elsevier

Professor John GF Cleland
Important Differences in Mode of Death Between Men and Women With Heart Failure Who Would Qualify for a Primary Prevention Implantable Cardioverter-Defibrillator

Article • Circulation, November 2012, Wolters Kluwer Health

Professor John GF Cleland
An atrial mass

Article • Journal of Cardiovascular Medicine, November 2012, Wolters Kluwer Health

Dr Pierpaolo Pellicori, Professor John GF Cleland
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

Article • Heart Failure Reviews, October 2012, Springer Science + Business Media

Professor John GF Cleland
Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve?

Article • Life Sciences, October 2012, Elsevier

Professor John GF Cleland
Diagnosis of elderly patients with heart failure

Article • European Journal of Heart Failure, October 2012, Wiley

Professor John GF Cleland
Heart failure—does it matter whether LVEF is reduced?

Article • The Lancet, October 2012, Elsevier

Professor John GF Cleland
Anticoagulation in heart failure: current status and future direction

Article • Heart Failure Reviews, September 2012, Springer Science + Business Media

Professor John GF Cleland
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management

Article • Heart Rhythm, September 2012, Elsevier

Professor John GF Cleland
Minimally clinically important difference in chronic breathlessness: Every little helps

Article • American Heart Journal, August 2012, Elsevier

Professor John GF Cleland
Standardized Reporting Criteria for Studies Evaluating Suspected Acute Heart Failure Syndromes in the Emergency Department

Article • Journal of the American College of Cardiology, August 2012, Elsevier

Professor John GF Cleland
Heart rate achieved or beta-blocker dose in patients with chronic heart failure: which is the better target?

Article • European Journal of Heart Failure, July 2012, Wiley

Professor John GF Cleland
Renal artery stenosis: an innocent bystander or an independent predictor of worse outcome in patients with chronic heart failure? A magnetic resonance imaging study

Article • European Journal of Heart Failure, July 2012, Wiley

Professor John GF Cleland
The PROTECT in‐hospital risk model: 7‐day outcome in patients hospitalized with acute heart failure and renal dysfunction

Article • European Journal of Heart Failure, June 2012, Oxford University Press (OUP)

Dr Robert John Mentz, Professor John GF Cleland
Experiences of air travel in patients with chronic heart failure

Article • International Journal of Cardiology, June 2012, Elsevier

Professor John GF Cleland
Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial

Article • European Journal of Heart Failure, June 2012, Wiley

Professor John GF Cleland
Soluble guanylate cyclase: a potential therapeutic target for heart failure

Article • Heart Failure Reviews, May 2012, Springer Science + Business Media

Professor John GF Cleland
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure

Article • Heart Failure Reviews, May 2012, Springer Science + Business Media

Professor John GF Cleland
A comparative study of missing value imputation with multiclass classification for clinical heart failure data

Article • May 2012, Institute of Electrical & Electronics Engineers (IEEE)

Professor John GF Cleland
Body mass index is related to the perception of exertional breathlessness in patients presenting with dyspnoea of unknown origin

Article • International Journal of Cardiology, May 2012, Elsevier

Professor John GF Cleland
Handling missing values in data mining - A case study of heart failure dataset

Article • May 2012, Institute of Electrical & Electronics Engineers (IEEE)

Professor John GF Cleland
Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study

Article • European Journal of Heart Failure, May 2012, Wiley

Professor John GF Cleland
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Article • European Heart Journal, April 2012, European Society of Cardiology

Professor john j mcmurray, Professor John GF Cleland
People with disabilities: the forgotten victims of violence

Article • The Lancet, April 2012, Elsevier

Professor John GF Cleland
Role of Antithrombotic Agents in Heart Failure

Article • Current Cardiology Reports, March 2012, Springer Science + Business Media

Professor John GF Cleland
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

Article • European Heart Journal, March 2012, European Society of Cardiology

Professor john j mcmurray, Professor John GF Cleland
Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis

Article • Heart Failure Reviews, March 2012, Springer Science + Business Media

Dr Pierpaolo Pellicori, Professor John GF Cleland
Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

Article • European Journal of Heart Failure, March 2012, Wiley

Professor john j mcmurray, Professor John GF Cleland
Prevalence of, Associations With, and Prognostic Value of Tricuspid Annular Plane Systolic Excursion (TAPSE) Among Out-Patients Referred for the Evaluation of Heart Failure

Article • Journal of Cardiac Failure, March 2012, Elsevier

Professor John GF Cleland
The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment

Article • Drug Safety, March 2012, Springer Science + Business Media

Professor John GF Cleland
Targeting myocardial substrate metabolism in heart failure: potential for new therapies

Article • European Journal of Heart Failure, February 2012, Wiley

Professor John GF Cleland
Systematic Reporting Bias in Meta-analyses of Trials of Aspirin for the Primary Prevention of Cardiovascular Disease

Article • The American Journal of Medicine, February 2012, Elsevier

Professor John GF Cleland
Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction

Article • Circulation, January 2012, Wolters Kluwer Health

Professor John GF Cleland
Abnormalities of the Ventilatory Equivalent for Carbon Dioxide in Patients with Chronic Heart Failure

Article • Pulmonary Medicine, January 2012, Hindawi Publishing Corporation

Professor John GF Cleland
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial

Article • European Journal of Heart Failure, January 2012, Wiley

Professor John GF Cleland
The European CRT Survey: 1 year (9-15 months) follow-up results

Article • European Journal of Heart Failure, January 2012, Wiley

Professor John GF Cleland
Use of Carotid Intima-Media Thickness Regression to Guide Therapy and Management of Cardiac Risks

Article • Current Treatment Options in Cardiovascular Medicine, December 2011, Springer Science + Business Media

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology Meeting 2011: ARISTOTLE, SMART-AV: QLV substudy, SHIFT: echocardiography and quality of life substudies, European CRT Survey, and Basic Science Update

Article • European Journal of Heart Failure, December 2011, Wiley

Professor John GF Cleland
Does the physical examination still have a role in patients with suspected heart failure?

Article • European Journal of Heart Failure, December 2011, Wiley

Professor John GF Cleland
Right and left bundle branch block as predictors of long-term mortality following myocardial infarction

Article • European Journal of Heart Failure, December 2011, Wiley

Professor John GF Cleland
The determinants of clinical outcome and clinical response to CRT are not the same

Article • Heart Failure Reviews, November 2011, Springer Science + Business Media

Professor John GF Cleland
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Article • American Heart Journal, November 2011, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart Failure

Article • Circulation Heart Failure, November 2011, Wolters Kluwer Health

Professor John GF Cleland
Atherosclerotic disease of the abdominal aorta and its branches: prognostic implications in patients with heart failure

Article • Heart Failure Reviews, October 2011, Springer Science + Business Media

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology Heart Failure meeting 2011: TEHAF, WHICH, CARVIVA, and atrial fibrillation in GISSI-HF and EMPHASIS-HF

Article • European Journal of Heart Failure, October 2011, Wiley

Professor John GF Cleland
Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: A cardiovascular magnetic resonance study

Article • Journal of Cardiovascular Magnetic Resonance, September 2011, Springer Science + Business Media

Professor John GF Cleland
Increasing knowledge and changing views in cardiac resynchronization therapy

Article • Heart Failure Reviews, September 2011, Springer Science + Business Media

Professor John GF Cleland
Limited role for ivabradine in the treatment of chronic heart failure

Article • Heart, September 2011, BMJ

Professor John GF Cleland
Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period

Article • Heart, September 2011, BMJ

Professor John GF Cleland
Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial

Article • European Journal of Heart Failure, September 2011, Wiley

Professor David Torgerson, Professor John GF Cleland
Questioning the predictive role of carotid intima–media thickness

Article • Future Cardiology, September 2011, Future Medicine

Professor John GF Cleland
The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades

Article • European Journal of Heart Failure, September 2011, Wiley

Professor John GF Cleland
Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Coc

Article • European Journal of Heart Failure, September 2011, Wiley

Professor John GF Cleland
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

Article • The Lancet, August 2011, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II

Article • European Journal of Heart Failure, July 2011, Wiley

Professor John GF Cleland
Revascularization for patients with heart failure. Inconsistencies between theory and practice

Article • European Journal of Heart Failure, July 2011, Wiley

Professor John GF Cleland
Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction: Findings From the I-PRESERVE Trial

Article • Circulation Heart Failure, June 2011, Wolters Kluwer Health

Professor john j mcmurray, Professor John GF Cleland
The Authors' reply

Article • Heart, June 2011, BMJ

Professor John GF Cleland
It makes SENSE to take a safer road

Article • European Heart Journal, May 2011, European Society of Cardiology

Professor John GF Cleland
Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction

Article • Journal of the American College of Cardiology, May 2011, Elsevier

Professor John GF Cleland
Prognostic significance of different measures of the ventilation-carbon dioxide relation in patients with suspected heart failure

Article • European Journal of Heart Failure, May 2011, Wiley

Professor John GF Cleland
Clinical Trials Update from the American Heart Association Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT

Article • European Journal of Heart Failure, April 2011, Oxford University Press (OUP)

Dr Pierpaolo Pellicori, Professor John GF Cleland
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy

Article • European Heart Journal, April 2011, European Society of Cardiology

Professor John GF Cleland
Telemonitoring in Patients with Heart Failure

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2011, New England Journal of Medicine (NEJM/MMS)

Professor John GF Cleland
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study

Article • European Heart Journal, March 2011, European Society of Cardiology

Professor John GF Cleland
A comparison between monophasic and biphasic defibrillation for the cardioversion of persistent atrial fibrillation in patients with and without heart failure

Article • International Journal of Cardiology, March 2011, Elsevier

Professor John GF Cleland
Body mass indices and outcome in patients with chronic heart failure

Article • European Journal of Heart Failure, February 2011, Wiley

Professor John GF Cleland
Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status – Do we need specificity for sex and beta-blockers?

Article • International Journal of Cardiology, February 2011, Elsevier

Professor John GF Cleland
The Heart Failure Revascularisation Trial (HEART)

Article • European Journal of Heart Failure, February 2011, Wiley

Professor John GF Cleland
Unmasking the truth

Article • BMJ Case Reports, January 2011, BMJ

Professor John GF Cleland
Relationship between right ventricular volumes measured by cardiac magnetic resonance imaging and prognosis in patients with chronic heart failure

Article • European Journal of Heart Failure, January 2011, Wiley

Professor John GF Cleland
The national heart failure audit for England and Wales 2008-2009

Article • Heart, December 2010, BMJ

Professor John GF Cleland
Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)

Article • Journal of Cachexia Sarcopenia and Muscle, December 2010, Wiley

Professor Giuseppe M C Rosano, Professor John GF Cleland
Clinical trials update from the European Society of Cardiology Meeting 2010: SHIFT, PEARL-HF, STAR-heart, and HEBE-III

Article • European Journal of Heart Failure, November 2010, Wiley

Professor John GF Cleland
La terapia de resincronización es coste-efectiva

Article • Revista Española de Cardiología, November 2010, Elsevier

Professor John GF Cleland
An Entirely Subcutaneous Implantable Cardioverter–Defibrillator

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2010, New England Journal of Medicine (NEJM/MMS)

Professor John GF Cleland
Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2010, New England Journal of Medicine (NEJM/MMS)

Professor John GF Cleland, Professor Dmitry Zateyshchikov
Coenzyme Q10, Rosuvastatin, and Clinical Outcomes in Heart Failure

Article • Journal of the American College of Cardiology, October 2010, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Enlisting the Help of the Largest Health Care Workforce—Patients

Article • JAMA, September 2010, American Medical Association (AMA)

Professor John GF Cleland
Editorialists' reply

Article • BMJ, September 2010, BMJ

Professor John GF Cleland
Emerging Therapies for Heart Failure

Article • September 2010, Wiley

Professor John GF Cleland
Applying evidence-based device care in cardiovascular patients: which patient with heart failure and what device?

Article • The Journal of the Royal College of Physicians of Edinburgh, September 2010, Royal College of Physicians of Edinburgh

Professor John GF Cleland
Cardiac output does not limit submaximal exercise capacity in patients with chronic heart failure

Article • European Journal of Heart Failure, September 2010, Wiley

Professor John GF Cleland
Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure

Article • European Heart Journal, August 2010, European Society of Cardiology

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology Heart Failure Meeting 2010: TRIDENT 1, BENEFICIAL, CUPID, RFA-HF, MUSIC, DUEL, handheld BNP, phrenic nerve stimulation, CHAMPION and CABG with CRT study

Article • European Journal of Heart Failure, August 2010, Wiley

Professor John GF Cleland
Calcium supplements in people with osteoporosis

Article • BMJ, July 2010, BMJ

Professor John GF Cleland
Letter by Begg et al Regarding Article, “The Effects of Vitamin D Supplementation on Physical Function and Quality of Life in Older Heart Failure Patients: A Randomized Controlled Trial”

Article • Circulation Heart Failure, July 2010, Wolters Kluwer Health

Professor John GF Cleland
Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR

Article • European Journal of Heart Failure, June 2010, Wiley

Professor John GF Cleland
Should We Be Trying to Define Responders to Cardiac Resynchronization Therapy?

Article • JACC Cardiovascular Imaging, May 2010, Elsevier

Professor John GF Cleland
Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine

Article • European Journal of Heart Failure, April 2010, Wiley

Professor john j mcmurray, Professor John GF Cleland
Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study

Article • European Journal of Heart Failure, April 2010, Wiley

Professor John GF Cleland
Reply

Article • Journal of the American College of Cardiology, April 2010, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United Kingdom

Article • International Journal of Technology Assessment in Health Care, April 2010, Cambridge University Press

Professor John GF Cleland, Catriona McDaid
Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes: Lessons Learned and Directions Forward

Article • Circulation Heart Failure, March 2010, Wolters Kluwer Health

Professor john j mcmurray, Professor John GF Cleland
Long-term aspirin for coronary artery disease: are we being deceived by a biased presentation of the evidence?

Article • Future Cardiology, March 2010, Future Medicine

Professor John GF Cleland
Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure - a COMET substudy

Article • Thrombosis Research, February 2010, Elsevier

Professor John GF Cleland
Defibrillators—a shocking therapy for cardiomyopathy?

Article • Nature Reviews Cardiology, February 2010, Springer Science + Business Media

Professor John GF Cleland
Clinical trials update from the American Heart Association meeting 2009: HEAAL, FAIR-HF, J-CHF, HeartMate II, PACE and a meta-analysis of dose-ranging studies of beta-blockers in heart failure

Article • European Journal of Heart Failure, January 2010, Wiley

Professor John GF Cleland
Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1

Article • European Journal of Heart Failure, January 2010, Wiley

Professor John GF Cleland
Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review

Article • European Journal of Heart Failure, January 2010, Wiley

Professor John GF Cleland
Lack of Diastolic Reserve in Patients With Heart Failure and Normal Ejection Fraction

Article • Circulation Heart Failure, January 2010, Wolters Kluwer Health

Professor John GF Cleland
Predictors of short term mortality in heart failure — Insights from the Euro Heart Failure survey

Article • International Journal of Cardiology, January 2010, Elsevier

Professor John GF Cleland
The Atrial Fibrillation Paradox of Heart Failure

Article • Congestive Heart Failure, January 2010, Wiley

Professor John GF Cleland
Declining In-Hospital Mortality and Increasing Heart Failure Incidence in Elderly Patients With First Myocardial Infarction

Article • Journal of the American College of Cardiology, December 2009, Elsevier

Professor John GF Cleland
Resource Use and Costs of Treatment With Anticoagulation and Antiplatelet Agents: Results of the WATCH Trial Economic Evaluation

Article • Journal of Cardiac Failure, December 2009, Elsevier

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT

Article • European Journal of Heart Failure, November 2009, Wiley

Professor John GF Cleland
Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure

Article • European Journal of Heart Failure, November 2009, Wiley

Professor John GF Cleland
Response to Letter Regarding Article, “Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial”

Article • Circulation, November 2009, Wolters Kluwer Health

Professor John GF Cleland
The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study

Article • European Heart Journal, November 2009, European Society of Cardiology

Professor John GF Cleland
Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin

Article • Journal of the American College of Cardiology, November 2009, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Is taking part in clinical trials good for your health? A cohort study

Article • European Journal of Heart Failure, October 2009, Wiley

Professor John GF Cleland
Micronutrient Deficiencies

Article • Journal of the American College of Cardiology, October 2009, Elsevier

Professor John GF Cleland
Aspirin in the primary prevention of vascular disease

Article • The Lancet, September 2009, Elsevier

Professor John GF Cleland
The European cardiac resynchronization therapy survey

Article • European Heart Journal, August 2009, European Society of Cardiology

Professor John GF Cleland
Impact of different diagnostic criteria on the prevalence and prognostic significance of exertional oscillatory ventilation in patients with chronic heart failure

Article • European Journal of Cardiovascular Prevention & Rehabilitation, August 2009, SAGE Publications

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology heart failure meeting 2009: CHANCE, B-Convinced, CHAT, CIBIS-ELD, and Signal-HF

Article • European Journal of Heart Failure, July 2009, Wiley

Professor John GF Cleland
Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial

Article • European Journal of Heart Failure, June 2009, Wiley

Professor John GF Cleland
Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study

Article • European Heart Journal, June 2009, European Society of Cardiology

Professor John GF Cleland
Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group

Article • American Heart Journal, June 2009, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA

Article • European Journal of Heart Failure, May 2009, Wiley

Professor John GF Cleland
Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation

Article • Journal of the American College of Cardiology, May 2009, Elsevier

Professor John GF Cleland
Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial

Article • European Journal of Heart Failure, April 2009, Wiley

Professor John GF Cleland
Obituary to Philip Poole-Wilson 1943-2009

Article • European Journal of Heart Failure, April 2009, Wiley

Professor John GF Cleland
Self-rated health and mortality in patients with chronic heart failure

Article • European Journal of Heart Failure, April 2009, Wiley

Professor John GF Cleland
Unconventional End Points in Cardiovascular Clinical Trials: Should We Be Moving Away From Morbidity and Mortality?

Article • Journal of Cardiac Failure, April 2009, Elsevier

Professor Philippe Gabriel STEG, Professor John GF Cleland
Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis

Article • Health Technology Assessment, April 2009, National Institute for Health Research

Professor John GF Cleland, Catriona McDaid
Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure

Article • Circulation, March 2009, Wolters Kluwer Health

Professor John GF Cleland
Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) study

Article • European Journal of Heart Failure, March 2009, Wiley

Professor John GF Cleland
The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction

Article • European Journal of Heart Failure, March 2009, Wiley

Professor John GF Cleland
A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study)

Article • Heart, March 2009, BMJ

Professor John GF Cleland
Current state of knowledge and experts’ perspective on the subcutaneous implantable cardioverter-defibrillator

Article • Journal of Interventional Cardiac Electrophysiology, March 2009, Springer Science + Business Media

Professor John GF Cleland
Effects of cardiac resynchronization therapy on long-term quality of life: An analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study

Article • American Heart Journal, March 2009, Elsevier

Professor John GF Cleland
Digoxin

Article • Circulation Heart Failure, March 2009, Wolters Kluwer Health

Professor John GF Cleland
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

Article • European Journal of Heart Failure, February 2009, Wiley

Professor john j mcmurray, Professor John GF Cleland
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β-blockers in SURVIVE†

Article • European Journal of Heart Failure, February 2009, Wiley

Professor John GF Cleland
Telemonitoring for heart failure: the only feasible option for good universal care?

Article • European Journal of Heart Failure, February 2009, Wiley

Professor John GF Cleland
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials

Article • European Journal of Heart Failure, February 2009, Wiley

Professor John GF Cleland
Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus

Article • Heart, February 2009, BMJ

Professor John GF Cleland
Smoking cessation in heart failure: easier said than done

Article • European Heart Journal, February 2009, European Society of Cardiology

Professor John GF Cleland
Cardiac Resynchronization Therapy

Article • Journal of the American College of Cardiology, February 2009, Elsevier

Professor John GF Cleland
Clinical trials update from the Heart Failure Society of America and the American Heart Association meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, thyroid hormone analogue study, HF-ACTION, I-PRESERVE, β-interferon study, BACH, and ATHENA

Article • European Journal of Heart Failure, January 2009, Wiley

Professor John GF Cleland
The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age

Article • Heart, January 2009, BMJ

Professor John GF Cleland
Prevalence and inter-relationship of different Doppler measures of dyssynchrony in patients with heart failure and prolonged QRS: a report from CARE-HF

Article • Cardiovascular Ultrasound, January 2009, Springer Science + Business Media

Professor John GF Cleland
The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial

Article • European Heart Journal, December 2008, European Society of Cardiology

Professor John GF Cleland
Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF

Article • European Journal of Heart Failure, November 2008, Wiley

Professor John GF Cleland
Oral levosimendan in patients with severe chronic heart failure-The PERSIST study

Article • European Journal of Heart Failure, November 2008, Wiley

Professor John GF Cleland
Successful treatment of heart failure with devices requires collaboration

Article • European Journal of Heart Failure, November 2008, Wiley

Professor John GF Cleland
Time for a proper study of aspirin after a vascular event?

Article • BMJ, November 2008, BMJ

Professor John GF Cleland
Cardiac resynchronization therapy: dyssynchrony imaging from a heart failure perspective

Article • Current Opinion in Cardiology, November 2008, Wolters Kluwer Health

Professor John GF Cleland
Ruling out heart failure in primary-care: The cost-benefit of pre-screening using NT-proBNP and QRS width

Article • International Journal of Cardiology, November 2008, Elsevier

Professor John GF Cleland
Predictors of Mortality From Pump Failure and Sudden Cardiac Death in Patients With Systolic Heart Failure and Left Ventricular Dyssynchrony: Results of the CARE-HF Trial

Article • Journal of Cardiac Failure, October 2008, Elsevier

Professor John GF Cleland
Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452

Article • European Journal of Heart Failure, September 2008, Wiley

Professor John GF Cleland
Interpretation of Amino-Terminal Pro-Brain Natriuretic Peptide Levels in the HPS and the CORONA Study

Article • Journal of the American College of Cardiology, September 2008, Elsevier

Professor John GF Cleland
State of the art: Using natriuretic peptide levels in clinical practice

Article • European Journal of Heart Failure, September 2008, Wiley

Professor John GF Cleland
Predicting the Long-Term Effects of Cardiac Resynchronization Therapy on Mortality From Baseline Variables and the Early Response

Article • Journal of the American College of Cardiology, August 2008, Elsevier

Professor John GF Cleland
The Epidemiology of Heart Failure

Article • July 2008, Oxford University Press (OUP)

Professor John GF Cleland
Structured telephone support or telemonitoring programs for patients with chronic heart failure

Article • July 2008, Wiley

Professor John GF Cleland
Design and Rationale of the URGENT Dyspnea Study: An International, Multicenter, Prospective Study

Article • American Journal of Therapeutics, July 2008, Wolters Kluwer Health

Professor John GF Cleland
The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure

Article • European Journal of Heart Failure, July 2008, Wiley

Professor John GF Cleland
New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey

Article • European Heart Journal, June 2008, European Society of Cardiology

Professor John GF Cleland
A Comparison of Patient and Physician-Rated New York Heart Association Class in a Community-Based Heart Failure Clinic

Article • Journal of Cardiac Failure, June 2008, Elsevier

Professor John GF Cleland
Cardiac resynchronisation therapy upgrade and occurrence of ventricular arrhythmia

Article • Heart, June 2008, BMJ

Professor John GF Cleland
Clinical trials update from the American College of Cardiology 2008: Carisma, Trends, meta-analysis of Cox-2 studies, Hat, on-Target, Hyvet, Accomplish, Momentum, Protect, Horizon-hf and Reverse

Article • European Journal of Heart Failure, June 2008, Wiley

Professor John GF Cleland
Perception of symptoms is out of proportion to cardiac pathology in patients with "diastolic heart failure"

Article • Heart, June 2008, BMJ

Professor John GF Cleland
The prognostic value of cardiopulmonary exercise testing with a peak respiratory exchange ratio of <1.0 in patients with chronic heart failure

Article • International Journal of Cardiology, June 2008, Elsevier

Professor John GF Cleland
Enhanced External Counterpulsation in the Treatment of Chronic Refractory Angina: A Long-term Follow-up Outcome from the International Enhanced External Counterpulsation Patient Registry

Article • Clinical Cardiology, April 2008, Wiley

Professor John GF Cleland
The effect of pharmacological stress on intraventricular dyssynchrony in left ventricular systolic dysfunction

Article • European Journal of Heart Failure, April 2008, Wiley

Professor John GF Cleland
The timing of development and subsequent clinical course of heart failure after a myocardial infarction

Article • European Heart Journal, March 2008, European Society of Cardiology

Professor John GF Cleland
Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study

Article • Heart, March 2008, BMJ

Professor John GF Cleland
Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely

Article • Heart, February 2008, BMJ

Professor John GF Cleland
A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach

Article • European Heart Journal, February 2008, European Society of Cardiology

Professor John GF Cleland
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition

Article • European Heart Journal, February 2008, European Society of Cardiology

Professor John GF Cleland
Relationship of high sensitivity C reactive peptide (hsCRP) to prognosis and other prognostic markers in outpatients with heart failure

Article • American Heart Journal, February 2008, Elsevier

Professor John GF Cleland
NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland

Article • Heart, February 2008, BMJ

Professor John GF Cleland
Classification of the Level of Evidence in International Guidelines for Acute and Chronic Heart Failure

Article • January 2008, Springer Science + Business Media

Professor John GF Cleland
Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy

Article • European Journal of Heart Failure, January 2008, Wiley

Professor John GF Cleland
Combining the ventilatory response to exercise and peak oxygen consumption is no better than peak oxygen consumption alone in predicting mortality in chronic heart failure

Article • European Journal of Heart Failure, January 2008, Wiley

Professor John GF Cleland
Is the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) the Answer to the Cholesterol Paradox in Heart Failure?

Article • Congestive Heart Failure, January 2008, Wiley

Professor John GF Cleland
Screening for left ventricular systolic dysfunction in high-risk patients in primary-care: A cost-benefit analysis

Article • European Journal of Heart Failure, December 2007, Wiley

Professor John GF Cleland
Rosuvastatin in Older Patients with Systolic Heart Failure

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2007, New England Journal of Medicine (NEJM/MMS)

Professor john j mcmurray, Professor John GF Cleland
Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure

Article • JAMA, November 2007, American Medical Association (AMA)

Professor john j mcmurray, Professor John GF Cleland
Effect of carvedilol and metoprolol on the mode of death in patients with heart failure

Article • European Journal of Heart Failure, November 2007, Wiley

Professor John GF Cleland
Recall of lifestyle advice in patients recently hospitalised with heart failure: A EuroHeart Failure Survey analysis

Article • European Journal of Heart Failure, November 2007, Wiley

Professor John GF Cleland
Role of angiotensin receptor blockers in the prevention and management of ischaemic stroke

Article • European Journal of Neurology, November 2007, Wiley

Professor John GF Cleland
The Cholesterol Paradox in Heart Failure

Article • Congestive Heart Failure, November 2007, Wiley

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure

Article • European Journal of Heart Failure, October 2007, Wiley

Professor John GF Cleland
Novel cardiac myosin activators for acute heart failure

Article • Expert Opinion on Investigational Drugs, October 2007, Informa Healthcare

Professor John GF Cleland
Worsening Renal Function and Prognosis in Heart Failure: Systematic Review and Meta-Analysis

Article • Journal of Cardiac Failure, October 2007, Elsevier

Professor John GF Cleland
Thiazolidinediones, deadly sins, surrogates, and elephants

Article • The Lancet, September 2007, Elsevier

Professor John GF Cleland
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET

Article • European Journal of Heart Failure, August 2007, Wiley

Professor John GF Cleland
Prognosis in Heart Failure with a Normal Ejection Fraction

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2007, New England Journal of Medicine (NEJM/MMS)

Professor John GF Cleland
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association

Article • European Heart Journal, August 2007, European Society of Cardiology

Professor John GF Cleland
Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia

Article • European Heart Journal, August 2007, European Society of Cardiology

Professor John GF Cleland
Cardiorespiratory Requirements of the 6-Min Walk Test in Older Patients with Left Ventricular Systolic Dysfunction and No Major Structural Heart Disease

Article • International Journal of Sports Medicine, August 2007, Thieme Publishing Group

Professor John GF Cleland
Clinical trials update from Heart Rhythm 2007 and Heart Failure 2007: CARISMA, PREPARE, DAVID II, SAVE-PACE, PROTECT and AREA-IN-CHF

Article • European Journal of Heart Failure, August 2007, Wiley

Professor John GF Cleland
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

Article • Heart, August 2007, BMJ

Professor John GF Cleland
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a β-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial

Article • European Journal of Heart Failure, August 2007, Wiley

Professor John GF Cleland
Prediction of Mode of Death in Heart Failure

Article • Circulation, July 2007, Wolters Kluwer Health

Professor John GF Cleland
Epidemiology, Associated Factors, and Prognostic Outcomes of Renal Artery Stenosis in Chronic Heart Failure Assessed by Magnetic Resonance Angiography

Article • The American Journal of Cardiology, July 2007, Elsevier

Professor John GF Cleland
Should Patients who have Persistent Severe Symptoms Receive a Left Ventricular Assist Device or Cardiac Resynchronization Therapy as the Next Step?

Article • Heart Failure Clinics, July 2007, Elsevier

Professor John GF Cleland
Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure

Article • American Heart Journal, June 2007, Elsevier

Professor John GF Cleland
Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I

Article • European Heart Journal, June 2007, European Society of Cardiology

Professor John GF Cleland
Prognostic value of the VE/VCO2 slope calculated from different time intervals in patients with suspected heart failure

Article • International Journal of Cardiology, June 2007, Elsevier

Professor John GF Cleland
The Safety of Amiodarone in Patients With Heart Failure

Article • Journal of Cardiac Failure, June 2007, Elsevier

Professor John GF Cleland
Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial

Article • European Heart Journal, May 2007, European Society of Cardiology

Professor John GF Cleland
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety

Article • EP Europace, May 2007, European Society of Cardiology

Professor John GF Cleland
Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS-diet

Article • European Journal of Heart Failure, May 2007, Wiley

Professor John GF Cleland
Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: A report from the SPORTIF III and V trials

Article • European Journal of Heart Failure, May 2007, Wiley

Professor John GF Cleland
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony

Article • European Heart Journal, May 2007, European Society of Cardiology

Professor John GF Cleland
Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge

Article • European Journal of Heart Failure, April 2007, Wiley

Professor John GF Cleland
Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis

Article • BMJ, April 2007, BMJ

Professor John GF Cleland
Fighting against sudden death: A single or multidisciplinary approach

Article • Journal of Interventional Cardiac Electrophysiology, April 2007, Springer Science + Business Media

Professor John GF Cleland
The effects of initiation or continuation of statin therapy on cholesterol level and all-cause mortality after the diagnosis of left ventricular systolic dysfunction

Article • American Heart Journal, April 2007, Elsevier

Professor John GF Cleland
Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure

Article • European Journal of Heart Failure, March 2007, Wiley

Professor John GF Cleland
Carvedilol Protects Better Against Vascular Events Than Metoprolol in Heart Failure

Article • Journal of the American College of Cardiology, March 2007, Elsevier

Professor John GF Cleland
Cardiac Resynchronization for Diabetic Heart Failure Patients

Article • Diabetes Care, March 2007, American Diabetes Association

Professor John GF Cleland
International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: Data from the EuroHeart Failure Survey

Article • European Journal of Heart Failure, March 2007, Wiley

Professor John GF Cleland
Nonpharmacologic Measures and Drug Compliance in Patients with Heart Failure: Data from the EuroHeart Failure Survey

Article • The American Journal of Cardiology, March 2007, Elsevier

Professor John GF Cleland
Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP

Article • EP Europace, February 2007, European Society of Cardiology

Professor John GF Cleland
Cardiac resynchronization therapy or atrio-biventricular pacing—what should it be called?

Article • Nature Clinical Practice Neurology, February 2007, Springer Science + Business Media

Professor John GF Cleland
An evaluation of two self-report screening measures for mood in an out-patient chronic heart failure population

Article • International Journal of Geriatric Psychiatry, January 2007, Wiley

Professor John GF Cleland
Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty

Article • European Journal of Heart Failure, January 2007, Wiley

Professor John GF Cleland
Practical Applications of Intravenous Diuretic Therapy in Decompensated Heart Failure

Article • The American Journal of Medicine, December 2006, Elsevier

Professor John GF Cleland
Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure

Article • European Heart Journal, November 2006, European Society of Cardiology

Professor John GF Cleland
The assessment of autonomic function in chronic atrial fibrillation: description of a non-invasive technique based on circadian rhythm of atrioventricular nodal functional refractory periods

Article • EP Europace, November 2006, European Society of Cardiology

Professor John GF Cleland
Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF

Article • European Journal of Heart Failure, October 2006, Wiley

Professor John GF Cleland
The effect of altering heart rate on ventricular function in patients with heart failure treated with β-blockers

Article • American Heart Journal, October 2006, Elsevier

Professor John GF Cleland
The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation

Article • European Heart Journal, October 2006, European Society of Cardiology

Professor John GF Cleland
The perindopril in elderly people with chronic heart failure (PEP-CHF) study

Article • European Heart Journal, October 2006, European Society of Cardiology

Professor John GF Cleland
Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study)

Article • European Journal of Echocardiography, October 2006, European Society of Cardiology

Professor John GF Cleland
New generation 3-dimensional echocardiography for left ventricular volumetric and functional measurements: Comparison with cardiac magnetic resonance

Article • European Journal of Echocardiography, October 2006, European Society of Cardiology

Professor John GF Cleland
Clinical trials update from the joint European Society and World Congress of Cardiology meeting: PEP-CHF, ACCLAIM and the HHH study

Article • European Journal of Heart Failure, October 2006, Wiley

Professor John GF Cleland
Randomized trials are also essential for device therapy: reply

Article • Journal of Internal Medicine, September 2006, Wiley

Professor John GF Cleland
The effect of ventricular pacing on measurements of left ventricular function: A comparison between echocardiographic methods and with radionuclide ventriculography☆

Article • European Journal of Echocardiography, August 2006, European Society of Cardiology

Professor John GF Cleland
Anemia, Renal Dysfunction, and Their Interaction in Patients With Chronic Heart Failure

Article • The American Journal of Cardiology, August 2006, Elsevier

Professor John GF Cleland
Cardiac resynchronization therapy: redefining the role of device therapy in heart failure

Article • Expert Review of Pharmacoeconomics & Outcomes Research, August 2006, Taylor & Francis

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902

Article • European Journal of Heart Failure, August 2006, Wiley

Professor John GF Cleland
Reply

Article • Journal of the American College of Cardiology, August 2006, Elsevier

Professor John GF Cleland
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]

Article • European Heart Journal, July 2006, European Society of Cardiology

Professor John GF Cleland
Effect of Cardiac Resynchronization on the Incidence of Atrial Fibrillation in Patients With Severe Heart Failure

Article • Circulation, July 2006, Wolters Kluwer Health

Professor John GF Cleland
The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator

Article • European Heart Journal, June 2006, European Society of Cardiology

Professor John GF Cleland
Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial

Article • Patient Education and Counseling, June 2006, Elsevier

Professor John GF Cleland
Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction - a systematic review and meta-analysis

Article • European Journal of Heart Failure, June 2006, Wiley

Professor John GF Cleland
The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET

Article • European Heart Journal, May 2006, European Society of Cardiology

Professor John GF Cleland
Excessive breathlessness in patients with diastolic heart failure

Article • Heart, May 2006, BMJ

Professor John GF Cleland
Chronic aspirin therapy for the prevention of cardiovascular events: a waste of time, or worse?

Article • Nature Clinical Practice Neurology, May 2006, Springer Science + Business Media

Professor John GF Cleland
Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease

Article • European Journal of Heart Failure, May 2006, Wiley

Professor John GF Cleland
Clinical trials update from the American College of Cardiology: Darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND

Article • European Journal of Heart Failure, May 2006, Wiley

Professor John GF Cleland
Diabetes Lowers Six-Minute Walk Test Performance in Heart Failure

Article • Journal of the American College of Cardiology, May 2006, Elsevier

Professor John GF Cleland
A Comparison of the Effects of Carvedilol and Metoprolol on Well-Being, Morbidity, and Mortality (the “Patient Journey”) in Patients With Heart Failure

Article • Journal of the American College of Cardiology, April 2006, Elsevier

Professor John GF Cleland
Pharmacokinetic and Pharmacodynamic Characteristics of β-Blockers: When Differences May Matter

Article • Journal of Cardiac Failure, April 2006, Elsevier

Professor John GF Cleland
Left ventricular morphology, global and longitudinal function in normal older individuals: A cardiac magnetic resonance study

Article • International Journal of Cardiology, March 2006, Elsevier

Professor John GF Cleland
The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina

Article • Journal of Internal Medicine, March 2006, Wiley

Professor John GF Cleland
Predicting peak oxygen uptake from 6-min walk test performance in male patients with left ventricular systolic dysfunction

Article • European Journal of Heart Failure, February 2006, Wiley

Professor John GF Cleland
Threats, opportunities, and statins in the modern management of heart failureThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

Article • European Heart Journal, February 2006, European Society of Cardiology

Professor John GF Cleland
Relation between severity of left ventricular systolic dysfunction and repolarisation abnormalities on the surface ECG: a report from the Euro heart failure survey

Article • Heart, February 2006, BMJ

Professor John GF Cleland
Metabolic remodeling in the aging heart

Article • Journal of Molecular and Cellular Cardiology, January 2006, Elsevier

Professor John GF Cleland
Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE

Article • European Journal of Heart Failure, December 2005, Wiley

Professor John GF Cleland
Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis

Article • European Heart Journal, December 2005, European Society of Cardiology

Professor John GF Cleland
Chronic heart failure, chronotropic incompetence, and the effects of blockade

Article • Heart, December 2005, BMJ

Professor John GF Cleland
How many patients need cardiac resynchronization therapy?The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

Article • European Heart Journal, December 2005, European Society of Cardiology

Professor John GF Cleland
N-terminal brain natriuretic peptide as a screening tool for heart failure in the pacemaker population

Article • European Heart Journal, November 2005, European Society of Cardiology

Professor John GF Cleland
Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial

Article • European Heart Journal, November 2005, European Society of Cardiology

Professor John GF Cleland
Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study

Article • Heart, October 2005, BMJ

Professor John GF Cleland
Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction

Article • Heart, October 2005, BMJ

Professor John GF Cleland
Cost effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial: reply

Article • European Heart Journal, October 2005, European Society of Cardiology

Professor John GF Cleland
Effect of a community heart failure clinic on uptake of blockers by patients with obstructive airways disease and heart failure

Article • Heart, October 2005, BMJ

Professor John GF Cleland
Atrial fibrillation management: a prospective survey in ESC Member Countries

Article • European Heart Journal, October 2005, European Society of Cardiology

Professor Massimo Fioranelli, Professor John GF Cleland
The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005)

Article • European Heart Journal, October 2005, European Society of Cardiology

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE

Article • European Journal of Heart Failure, October 2005, Wiley

Professor John GF Cleland
Metabolic gas kinetics depend upon the level of exercise performed

Article • European Journal of Heart Failure, October 2005, Wiley

Professor John GF Cleland
Poor Relationship Between Exercise Capacity and Spirometric Measurements in Patients With More Symptomatic Heart Failure

Article • Journal of Cardiac Failure, October 2005, Elsevier

Professor John GF Cleland
Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure

Article • European Heart Journal, September 2005, European Society of Cardiology

Professor John GF Cleland
ACC/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Chronic Heart Failure

Article • Circulation, September 2005, Wolters Kluwer Health

Professor John GF Cleland
Anemia and Chronic Heart Failure

Article • Circulation, September 2005, Wolters Kluwer Health

Professor John GF Cleland
ACC/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Chronic Heart Failure

Article • Journal of the American College of Cardiology, September 2005, Elsevier

Professor John GF Cleland
Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Versión resumida (actualización 2005)

Article • Revista Española de Cardiología, September 2005, Elsevier

Professor John GF Cleland
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure

Article • European Heart Journal, August 2005, European Society of Cardiology

Professor John GF Cleland
Clinical trials update from the American College of Cardiology meeting: CARE-HF and the Remission of Heart Failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER

Article • European Journal of Heart Failure, August 2005, Wiley

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: Darbepoetin alfa study, ECHOS, and ASCOT-BPLA

Article • European Journal of Heart Failure, August 2005, Wiley

Professor John GF Cleland
Do discharge codes underestimate hospitalisation due to heart failure? Validation study of hospital discharge coding for heart failure

Article • European Journal of Heart Failure, August 2005, Wiley

Professor John GF Cleland
Exploring symptoms in chronic heart failure

Article • European Journal of Heart Failure, August 2005, Wiley

Professor John GF Cleland
Meta-analysis does not show that cardiac resynchronisation reduces all-cause mortality

Article • International Journal of Cardiology, August 2005, Elsevier

Professor John GF Cleland
Once-Monthly Administration of Darbepoetin Alfa for the Treatment of Patients with Chronic Heart Failure and Anemia

Article • Journal of Cardiovascular Pharmacology, August 2005, Wolters Kluwer Health

Professor John GF Cleland
Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction

Article • European Journal of Heart Failure, August 2005, Wiley

Professor John GF Cleland
The diagnosis of heart failure in European primary care: The IMPROVEMENT Programme survey of perception and practice

Article • European Journal of Heart Failure, August 2005, Wiley

Professor John GF Cleland
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

Article • European Heart Journal, July 2005, European Society of Cardiology

Professor John GF Cleland
Cardiac-Resynchronization Therapy in Heart Failure

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2005, New England Journal of Medicine (NEJM/MMS)

Professor John GF Cleland
Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS)

Article • American Heart Journal, July 2005, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Multidisciplinary interventions in heart failure

Article • Heart, July 2005, BMJ

Professor John GF Cleland
Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction

Article • The American Journal of Medicine, July 2005, Elsevier

Professor John GF Cleland
β-Blockers, Exercise, and Ventilation in Chronic Heart Failure

Article • Journal of Cardiac Failure, June 2005, Elsevier

Professor John GF Cleland
Exchange of β-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial)

Article • European Journal of Heart Failure, May 2005, Wiley

Professor John GF Cleland
The effects of long-term β-blockade on the ventilatory responses to exercise in chronic heart failure

Article • European Journal of Heart Failure, May 2005, Wiley

Professor John GF Cleland
Atherosclerotic renovascular disease in chronic heart failure: should we intervene?

Article • European Heart Journal, May 2005, European Society of Cardiology

Professor John GF Cleland
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

Article • European Heart Journal, May 2005, European Society of Cardiology

Professor John GF Cleland
Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction

Article • Heart, May 2005, BMJ

Professor John GF Cleland
Hierarchical cardiac MRI segmentation using shaped region-interface descriptors

Article • International Congress Series, May 2005, Elsevier

Professor John GF Cleland, Christian Langton
Noninvasive Home Telemonitoring for Patients With Heart Failure at High Risk of Recurrent Admission and Death

Article • Journal of the American College of Cardiology, May 2005, Elsevier

Professor John GF Cleland
Symptoms in Patients With Heart Failure are Prognostic Predictors: Insights From COMET

Article • Journal of Cardiac Failure, May 2005, Elsevier

Professor John GF Cleland
The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure

Article • European Heart Journal, April 2005, European Society of Cardiology

Professor John GF Cleland
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2005, New England Journal of Medicine (NEJM/MMS)

Professor John GF Cleland
Are There Clinically Important Differences Between Beta-Blockers in Heart Failure?

Article • Heart Failure Clinics, April 2005, Elsevier

Professor John GF Cleland
Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review

Article • European Heart Journal, March 2005, European Society of Cardiology

Professor John GF Cleland
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET

Article • European Heart Journal, March 2005, European Society of Cardiology

Professor John GF Cleland
Longitudinal myocardial dysfunction in healthy older subjects as a manifestation of cardiac ageing

Article • Age and Ageing, February 2005, Oxford University Press (OUP)

Professor John GF Cleland
Baseline characteristics of patients recruited into the CARE-HF study

Article • European Journal of Heart Failure, February 2005, Wiley

Professor John GF Cleland
The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study

Article • European Journal of Heart Failure, February 2005, Wiley

Professor John GF Cleland
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

Article • American Heart Journal, February 2005, Elsevier

Professor John GF Cleland
Patients with treatable malignant diseases -- including heart failure -- are entitled to specialist care

Article • Canadian Medical Association Journal, January 2005, Canadian Medical Association (CMA)

Professor John GF Cleland
Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study

Article • European Journal of Heart Failure, January 2005, Wiley

Professor John GF Cleland
Comparison of selective ETAand ETBreceptor antagonists in patients with chronic heart failure

Article • European Journal of Heart Failure, January 2005, Wiley

Professor John GF Cleland
Letter from the outgoing Editor-in-Chief of the European Journal of Heart Failure

Article • European Journal of Heart Failure, January 2005, Wiley

Professor John GF Cleland
Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD

Article • European Journal of Heart Failure, December 2004, Wiley

Professor John GF Cleland
Trial finds no evidence that aspirin and warfarin improve outcomes in people with heart failure

Article • Evidence-based Cardiovascular Medicine, December 2004, Elsevier

Professor John GF Cleland
The prevalence of abnormal glucose regulation in patients with coronary artery disease across EuropeThe Euro Heart Survey on diabetes and the heart

Article • European Heart Journal, November 2004, European Society of Cardiology

Professor John GF Cleland
Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?

Article • Nature Clinical Practice Neurology, November 2004, Springer Science + Business Media

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial

Article • European Journal of Heart Failure, October 2004, Wiley

Professor John GF Cleland
Diagnosing heart failure in primary care: lessons from EPICA

Article • European Journal of Heart Failure, October 2004, Wiley

Professor John GF Cleland
Exercise capacity and cardiac function assessed by tissue Doppler imaging in chronic heart failure

Article • Heart, October 2004, BMJ

Professor John GF Cleland
The utility of a comprehensive cardiac magnetic resonance examination for the evaluation of patients with heart failure

Article • Heart, October 2004, BMJ

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy

Article • European Journal of Heart Failure, August 2004, Wiley

Professor John GF Cleland
Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe

Article • European Journal of Heart Failure, August 2004, Wiley

Professor John GF Cleland
The TORCH (TOwards a Revolution in COPD Health) survival study protocol: Fig. 1.—

Article • European Respiratory Journal, August 2004, European Respiratory Society (ERS)

Professor John GF Cleland
The Warfarin/Aspirin study in heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

Article • American Heart Journal, July 2004, Elsevier

Professor John GF Cleland
Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey

Article • European Heart Journal, July 2004, European Society of Cardiology

Professor John GF Cleland
A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design

Article • Journal of Cardiac Failure, June 2004, Elsevier

Professor John GF Cleland
Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure

Article • European Journal of Heart Failure, June 2004, Wiley

Professor John GF Cleland
Diastolic heart failure. Paroxysmal or chronic?

Article • European Journal of Heart Failure, June 2004, Wiley

Professor John GF Cleland
Letter to the editor

Article • European Journal of Heart Failure, June 2004, Wiley

Professor John GF Cleland
Are hematinic deficiencies the cause of anemia in chronic heart failure?

Article • American Heart Journal, May 2004, Elsevier

Professor John GF Cleland
The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics

Article • Journal of Cardiac Failure, April 2004, Elsevier

Professor John GF Cleland
The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometry

Article • Journal of Cardiac Failure, April 2004, Elsevier

Professor John GF Cleland
A Description of the Clinical Characteristics at Baseline of Patients Recruited into the Carvedilol or Metoprolol European Trial (COMET)

Article • Cardiovascular Drugs and Therapy, March 2004, Springer Science + Business Media

Professor John GF Cleland
Controlling persistent atrial fibrillation

Article • QJM, March 2004, Oxford University Press (OUP)

Professor John GF Cleland
Natriuretic peptides for heart failure. Fashionable? Useful? Necessary?

Article • European Journal of Heart Failure, March 2004, Wiley

Professor John GF Cleland
A method to reduce loss to follow-up in clinical trials: informed, withdrawal of consent

Article • European Journal of Heart Failure, January 2004, Wiley

Professor John GF Cleland
Carvedilol was more effective than metoprolol tartrate for lowering mortality in chronic heart failure

Article • Evidence-Based Medicine, January 2004, BMJ

Professor John GF Cleland
Clinical trials update from the American Heart Association meeting: Ω-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PA

Article • European Journal of Heart Failure, January 2004, Wiley

Professor John GF Cleland
Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure

Article • Expert Review of Cardiovascular Therapy, January 2004, Taylor & Francis

Professor John GF Cleland
Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

Article • Journal of the American College of Cardiology, December 2003, Elsevier

Professor John GF Cleland
Carvedilol reduces mortality compared with metoprolol in chronic heart failure

Article • Evidence-based Cardiovascular Medicine, December 2003, Elsevier

Professor John GF Cleland
Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity

Article • British Journal of Clinical Pharmacology, November 2003, Wiley

Professor John GF Cleland
The CHARM programme

Article • The Lancet, November 2003, Elsevier

Professor john j mcmurray, Professor John GF Cleland
A systematic review of telemonitoring for the management of heart failure

Article • European Journal of Heart Failure, October 2003, Wiley

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM

Article • European Journal of Heart Failure, October 2003, Wiley

Professor John GF Cleland
Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure

Article • Journal of the American College of Cardiology, October 2003, Elsevier

Professor John GF Cleland
Myocardial dysfunction: hibernation and remodelling

Article • The Lancet, October 2003, Elsevier

Professor John GF Cleland
Reliability of reporting left ventricular systolic function by echocardiography: A systematic review of 3 methods

Article • American Heart Journal, September 2003, Elsevier

Professor John GF Cleland
Cardiac resynchronization halves death from heart failure

Article • Evidence-based Cardiovascular Medicine, September 2003, Elsevier

Professor John GF Cleland
Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color doppler tissue imaging

Article • Journal of the American Society of Echocardiography, September 2003, Elsevier

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology Heart Failure meeting: COMET, COMPANION, Tezosentan and SHAPE

Article • European Journal of Heart Failure, August 2003, Wiley

Professor John GF Cleland
Pain Management in Patients With Osteoarthritis

Article • JAMA, July 2003, American Medical Association (AMA)

Professor John GF Cleland
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

Article • The Lancet, July 2003, Elsevier

Professor John GF Cleland
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial

Article • The Lancet, July 2003, Elsevier

Professor John GF Cleland
The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population

Article • European Heart Journal, June 2003, European Society of Cardiology

Professor John GF Cleland
The heart failure revascularisation trial (HEART): rationale, design and methodology

Article • European Journal of Heart Failure, June 2003, Wiley

Professor John GF Cleland
Update of clinical trials from the American College of Cardiology 2003. EPHESUS, SPORTIF-III, ASCOT, COMPANION, UK-PACE and T-wave alternans

Article • European Journal of Heart Failure, June 2003, Wiley

Professor John GF Cleland
The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatment

Article • European Heart Journal, March 2003, European Society of Cardiology

Professor John GF Cleland
The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis

Article • European Heart Journal, March 2003, European Society of Cardiology

Professor John GF Cleland
Levosimendan reduces mortality compared wtih dobutamine in severe low output heart failure

Article • Evidence-based Cardiovascular Medicine, March 2003, Elsevier

Professor John GF Cleland
There is little evidence that intravenous inotropes improve outcomes in heart failure

Article • Evidence-based Cardiovascular Medicine, March 2003, Elsevier

Professor John GF Cleland
β-Blockers for heart failure: why, which, when, and where

Article • Medical Clinics of North America, March 2003, Elsevier

Professor John GF Cleland
Effect of Age and Sex on Left Atrial Morphology and Function

Article • European Journal of Echocardiography, March 2003, Oxford University Press (OUP)

Professor John GF Cleland
A Happy and Prosperous New Year to All Our Readers!

Article • European Journal of Heart Failure, January 2003, Wiley

Professor John GF Cleland
Clinical trials update from the American Heart Association meeting: PROSPER, DIAL, home care monitoring trials, immune modulation therapy, COMPANION and anaemia in heart failure

Article • European Journal of Heart Failure, January 2003, Wiley

Professor John GF Cleland
Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial

Article • European Journal of Heart Failure, January 2003, Wiley

Professor John GF Cleland
Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function

Article • The American Journal of Cardiology, November 2002, Elsevier

Professor John GF Cleland
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey

Article • The Lancet, November 2002, Elsevier

Professor John GF Cleland
Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II

Article • European Journal of Heart Failure, October 2002, Wiley

Professor John GF Cleland
Airway resistance in chronic heart failure measured by impulse oscillometry

Article • Journal of Cardiac Failure, August 2002, Elsevier

Professor John GF Cleland
Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH

Article • European Journal of Heart Failure, August 2002, Wiley

Professor John GF Cleland
The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis

Article • European Journal of Heart Failure, August 2002, Wiley

Professor John GF Cleland
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial

Article • The Lancet, July 2002, Elsevier

Professor John GF Cleland
Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL

Article • European Journal of Heart Failure, June 2002, Wiley

Professor John GF Cleland
How to assess new treatments for the management of heart failure: composite scoring systems to assess the patients’ clinical journey

Article • European Journal of Heart Failure, June 2002, Wiley

Professor John GF Cleland
Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET

Article • European Journal of Heart Failure, June 2002, Wiley

Professor John GF Cleland
The European Journal of Heart Failure; update on the story so far!

Article • European Journal of Heart Failure, June 2002, Wiley

Professor John GF Cleland
Levosimendan: a new era for inodilator therapy for heart failure?

Article • Current Opinion in Cardiology, May 2002, Wolters Kluwer Health

Professor John GF Cleland
Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH

Article • European Journal of Heart Failure, January 2002, Wiley

Professor John GF Cleland
Diastolic heart failure: neglected or misdiagnosed?

Article • Journal of the American College of Cardiology, January 2002, Elsevier

Professor John GF Cleland
Is aspirin ″the weakest link” in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease

Article • Progress in Cardiovascular Diseases, January 2002, Elsevier

Professor John GF Cleland
No reduction in cardiovascular risk with NSAIDs—including aspirin?

Article • The Lancet, January 2002, Elsevier

Professor John GF Cleland
Article • Heart Failure Reviews, January 2002, Springer Science + Business Media

Professor John GF Cleland
Article • Heart Failure Reviews, January 2002, Springer Science + Business Media

Professor John GF Cleland
ACE Inhibitors for ‘Diastolic’ Heart Failure? Reasons not to jump to premature conclusions about the efficacy of ACE inhibitors among older patients with heart failure

Article • European Journal of Heart Failure, December 2001, Wiley

Professor John GF Cleland
Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology - WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME

Article • European Journal of Heart Failure, December 2001, Wiley

Professor John GF Cleland
Validation of an echocardiographic wall motion index in heart failure due to ischaemic heart disease

Article • European Journal of Heart Failure, December 2001, Wiley

Professor John GF Cleland
Endothelin antagonists for chronic heart failure: do they have a role?

Article • European Heart Journal, October 2001, European Society of Cardiology

Professor John GF Cleland
What is the optimal medical management of ischaemic heart failure?

Article • British Medical Bulletin, October 2001, Oxford University Press (OUP)

Professor John GF Cleland
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study

Article • European Heart Journal, September 2001, European Society of Cardiology

Professor John GF Cleland
Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?

Article • Current Opinion in Nephrology & Hypertension, September 2001, Wolters Kluwer Health

Professor John GF Cleland
Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF

Article • European Journal of Heart Failure, August 2001, Wiley

Professor John GF Cleland
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points

Article • European Journal of Heart Failure, August 2001, Wiley

Professor John GF Cleland
Chronic heart failure and micronutrients

Article • Journal of the American College of Cardiology, June 2001, Elsevier

Professor John GF Cleland
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001

Article • European Journal of Heart Failure, June 2001, Wiley

Professor John GF Cleland
The heart failure epidemic: exactly how big is it?

Article • European Heart Journal, April 2001, European Society of Cardiology

Professor John GF Cleland
How do you measure exercise capacity in chronic heart failure?

Article • European Heart Journal, April 2001, European Society of Cardiology

Professor John GF Cleland
What is the optimal medical management of ischemic heart failure?

Article • Progress in Cardiovascular Diseases, March 2001, Elsevier

Professor John GF Cleland
Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges

Article • European Heart Journal, January 2001, European Society of Cardiology

Professor John GF Cleland
Recommendations for exercise testing in chronic heart faliure patients

Article • European Heart Journal, January 2001, European Society of Cardiology

Professor John GF Cleland
Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myobl

Article • European Journal of Heart Failure, January 2001, Wiley

Professor John GF Cleland
Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART

Article • European Journal of Heart Failure, December 2000, Wiley

Professor John GF Cleland
Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study

Article • European Journal of Heart Failure, December 2000, Wiley

Professor John GF Cleland
Is the prognosis of heart failure improving?

Article • Journal of the American College of Cardiology, December 2000, Elsevier

Professor John GF Cleland
Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials

Article • European Journal of Heart Failure, September 2000, Wiley

Professor John GF Cleland
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable?

Article • European Heart Journal, August 2000, European Society of Cardiology

Professor John GF Cleland
Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension

Article • European Respiratory Journal, August 2000, European Respiratory Society (ERS)

Professor John GF Cleland
Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT

Article • European Journal of Heart Failure, June 2000, Wiley

Professor John GF Cleland
Systematic review of the management of atrial fibrillation in patients with heart failure

Article • European Heart Journal, April 2000, European Society of Cardiology

Professor John GF Cleland
Implantable left ventricular assist systems (LVAS): Recent results. A report from a series of meetings sponsored by the Study Group on Advanced Heart Failure of the Working Group on Heart Failure

Article • European Journal of Heart Failure, March 2000, Wiley

Professor John GF Cleland
Implantable left ventricular assist systems: clinical trials

Article • European Journal of Heart Failure, March 2000, Wiley

Professor John GF Cleland
Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure

Article • European Journal of Heart Failure, March 2000, Wiley

Professor John GF Cleland
The Carvedilol Hibernation Reversible Ischaemia Trial, Marker of Success (CHRISTMAS) study

Article • International Journal of Cardiology, February 2000, Elsevier

Professor John GF Cleland
Review: long-term beta-blocker use reduces mortality after myocardial infarction

Article • Evidence-Based Medicine, January 2000, BMJ

Professor John GF Cleland
Article • Heart Failure Reviews, January 2000, Springer Science + Business Media

Professor John GF Cleland
Disruption of the relationship between renin and atrial natriuretic peptide early in the course of ventricular dysfunction

Article • European Journal of Heart Failure, December 1999, Wiley

Professor John GF Cleland
The LIDO, HOPE, MOXCON and WASH studies

Article • European Journal of Heart Failure, December 1999, Wiley

Professor John GF Cleland
Depression and heart failure — not yet a target for therapy?

Article • European Heart Journal, November 1999, European Society of Cardiology

Professor John GF Cleland
Survival trends, coronary event rates, and the MONICA project

Article • The Lancet, September 1999, Elsevier

Professor John GF Cleland
Heart failure update

Article • European Journal of Heart Failure, August 1999, Wiley

Professor John GF Cleland
Is the prognosis of heart failure improving?

Article • European Journal of Heart Failure, August 1999, Wiley

Professor John GF Cleland
Perindopril for elderly people with chronic heart failure: the PEP-CHF study

Article • European Journal of Heart Failure, August 1999, Wiley

Professor John GF Cleland
Heart Failure - taking the lead

Article • European Journal of Heart Failure, June 1999, Wiley

Professor John GF Cleland
Heart Failure due to Ischaemic Heart Disease: Epidemiology, Pathophysiology and Progression

Article • Journal of Cardiovascular Pharmacology, June 1999, Wolters Kluwer Health

Professor John GF Cleland
Increasing awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative

Article • European Journal of Heart Failure, June 1999, Wiley

Professor John GF Cleland
The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS)

Article • European Journal of Heart Failure, June 1999, Wiley

Professor John GF Cleland
Update of REACH-1 and MERIT-HF clinical trials in heart failure

Article • European Journal of Heart Failure, June 1999, Wiley

Professor John GF Cleland
EndothelinBreceptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction

Article • Journal of the American College of Cardiology, March 1999, Elsevier

Professor john j mcmurray, Professor John GF Cleland
Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study

Article • European Journal of Heart Failure, March 1999, Wiley

Professor John GF Cleland
The WASH study (Warfarin/Aspirin Study in Heart failure) rationale, design and end-points

Article • European Journal of Heart Failure, March 1999, Wiley

Professor John GF Cleland
Update of recent clinical trials in heart failure and myocardial infarction

Article • European Journal of Heart Failure, March 1999, Wiley

Professor John GF Cleland
Editor's note

Article • European Journal of Heart Failure, March 1999, Wiley

Professor John GF Cleland
Sudden death in heart failure: vascular or electrical?

Article • European Journal of Heart Failure, March 1999, Wiley

Professor John GF Cleland
Article • Heart Failure Reviews, January 1999, Springer Science + Business Media

Professor John GF Cleland
Article • Heart Failure Reviews, January 1999, Springer Science + Business Media

Professor John GF Cleland
Etiology and response to drug treatment in heart failure

Article • Journal of the American College of Cardiology, November 1998, Elsevier

Professor John GF Cleland
Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction

Article • Cardiovascular Research, September 1998, European Society of Cardiology

Professor john j mcmurray, Professor John GF Cleland
Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995

Article • European Heart Journal, July 1998, European Society of Cardiology

Professor John GF Cleland
Risk stratification in chronic heart failure

Article • European Heart Journal, May 1998, European Society of Cardiology

Professor John GF Cleland
Regional differences in the characteristics and treatment of patients participating in an international heart failure trial

Article • Journal of Cardiac Failure, March 1998, Elsevier

Professor John GF Cleland
Economic implications of the Total Ischaemic Burden Bisoprolol Study (TIBBS) follow-up

Article • Journal of Medical Economics, January 1998, Informa Healthcare

Professor John GF Cleland
β-Blockers for Chronic Heart Failure: From Prejudice to Enlightenment

Article • Journal of Cardiovascular Pharmacology, January 1998, Wolters Kluwer Health

Professor John GF Cleland
Article • Cardiovascular Drugs and Therapy, January 1997, Springer Science + Business Media

Professor John GF Cleland
Effects of aging on neuroendocrine activation in subjects and patients in the presence and absence of heart failure with left ventricular systolic dysfunction

Article • The American Journal of Cardiology, June 1996, Elsevier

Professor John GF Cleland
Inhibition of the renin-angiotensin-aldosterone system in heart failure: new insights from basic clinical research

Article • Current Opinion in Cardiology, May 1996, Wolters Kluwer Health

Professor John GF Cleland
Shortened duration of post-ischemic hyperemic blood flow in the forearm of patients with heart failure

Article • The American Journal of Cardiology, February 1996, Elsevier

Professor John GF Cleland
Clinical Trials Report: Cardiovascular & Renal: Ongoing and planned clinical trials in chronic heart failure and left ventricular dysfunction

Article • Expert Opinion on Investigational Drugs, November 1995, Informa Healthcare

Professor john j mcmurray, Professor John GF Cleland
The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy

Article • The American Journal of Cardiology, October 1995, Elsevier

Professor John GF Cleland
Is aspirin safe for patients with heart failure?

Article • Heart, September 1995, BMJ

Professor John GF Cleland
Angiography and the aetiology of heart failure.

Article • Postgraduate Medical Journal, August 1995, BMJ

Professor John GF Cleland
Renal response to candoxatrilat in patients with heart failure

Article • Journal of the American College of Cardiology, May 1995, Elsevier

Professor John GF Cleland
ACE inhibitors in heart failure. What dose?

Article • Postgraduate Medical Journal, February 1995, BMJ

Professor John GF Cleland
Short-term effects of right atrial, right ventricular apical, and atrioventricular sequential pacing on myocardial oxygen consumption and cardiac efficiency in patients with coronary artery disease

Article • Heart, October 1994, BMJ

Professor John GF Cleland
ACE inhibitors for heart failure: a question of dose

Article • Heart, September 1994, BMJ

Professor John GF Cleland
ACE inhibitors: current understanding and future directions

Article • Heart, September 1994, BMJ

Professor John GF Cleland
How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?

Article • Heart, September 1994, BMJ

Professor John GF Cleland
Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?

Article • The Lancet, August 1994, Elsevier

Professor John GF Cleland
Optimising heart failure pharmacotherapy: the ideal combination

Article • Heart, August 1994, BMJ

Professor John GF Cleland
Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure

Article • American Heart Journal, March 1994, Elsevier

Professor Edward G D Tuddenham, Professor John GF Cleland
Sarcoid, amyloid and heart failure

Article • International Journal of Cardiology, September 1993, Elsevier

Professor John GF Cleland
Bronchial Hyperresponsiveness in Heart Failure

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 1993, New England Journal of Medicine (NEJM/MMS)

Professor John GF Cleland
Cardioreparation and the Concept of Modulating Cardiovascular Structure and Function

Article • Blood Pressure, January 1993, Taylor & Francis

Professor John GF Cleland
Modification of atherosclerosis by agents that do not lower cholesterol

Article • Heart, January 1993, BMJ

Professor John GF Cleland
A comparison of the effects of the selective peripheralα 1-blocker terazosin with the selectiveβ 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to-moderate essential hypertension

Article • Clinical Autonomic Research, December 1992, Springer Science + Business Media

Professor John GF Cleland
Angiotensin-converting enzyme inhibitors, left ventricular dysfunction, and early heart failure

Article • The American Journal of Cardiology, October 1992, Elsevier

Professor John GF Cleland
Impaired Left Lower Lobe Ventilation in Patients with Cardiomegaly

Article • CHEST Journal, May 1992, Elsevier

Professor John GF Cleland
Angiotensin converting enzyme inhibitors for hypertension and heart failure?

Article • Postgraduate Medical Journal, January 1992, BMJ

Professor John GF Cleland
Arrhythmias, catecholamines and electrolytes

Article • The American Journal of Cardiology, January 1988, Elsevier

Professor John GF Cleland
Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension.

Article • Heart, September 1987, BMJ

Professor John GF Cleland
The effects of captopril on serum digoxin and urinary urea and digoxin clearances in patients with congestive heart failure

Article • American Heart Journal, July 1986, Elsevier

Professor John GF Cleland
Combination of verapamil and beta blockers in systemic hypertension

Article • The American Journal of Cardiology, February 1986, Elsevier

Professor John GF Cleland
The effects of prostacyclin (PGI2) on haematological and haemodynamic parameters, and lung histology in puppies undergoing cardiopulmonary bypass surgery with profound hypothermia

Article • Prostaglandins Leukotrienes and Medicine, January 1985, Elsevier

Professor John GF Cleland
Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure

Article • The American Journal of Medicine, November 1984, Elsevier

Professor John GF Cleland

Search Kudos

Main menu

Discover

Subjects on Kudos

Services and resources

Admin

All Stories